[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2005074952A1 - Chinese medicine for treatment of irritable bowel sysndrome and the preparation thereof - Google Patents

Chinese medicine for treatment of irritable bowel sysndrome and the preparation thereof Download PDF

Info

Publication number
WO2005074952A1
WO2005074952A1 PCT/CN2005/000155 CN2005000155W WO2005074952A1 WO 2005074952 A1 WO2005074952 A1 WO 2005074952A1 CN 2005000155 W CN2005000155 W CN 2005000155W WO 2005074952 A1 WO2005074952 A1 WO 2005074952A1
Authority
WO
WIPO (PCT)
Prior art keywords
parts
soft
add
chinese medicine
traditional chinese
Prior art date
Application number
PCT/CN2005/000155
Other languages
French (fr)
Chinese (zh)
Inventor
Zunhong Ke
Original Assignee
Chengdu Kanghong Technology Enterprises (Group) Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Kanghong Technology Enterprises (Group) Co., Ltd. filed Critical Chengdu Kanghong Technology Enterprises (Group) Co., Ltd.
Publication of WO2005074952A1 publication Critical patent/WO2005074952A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Definitions

  • the invention relates to the field of pharmaceutical preparations, in particular to a traditional Chinese medicine for treating irritable bowel syndrome and a preparation method thereof. Background technique
  • IBS Irritable bowel syndrome
  • traditional Chinese medicine classifies irritable bowel syndrome in the categories of diarrhea, constipation, abdominal pain, stagnation, depression, gathering, intestinal dysfunction, etc. It is believed that it can be caused by exogenous evil qi, internal injury diet, and weak body. Caused by chronic diseases, overwork and other causes, liver stagnation, spleen deficiency, kidney deficiency, stasis, blood stasis and other syndromes are common clinically, and there are many mixed syndromes, but they have different emphasis. According to different classifications, it can be divided into two, three or eight syndrome types, which are usually divided into diarrhea type, constipation type and mixed type three types, among which the diarrhea type is the most common.
  • the present invention aims to provide a new Chinese medicine for treating irritable bowel syndrome, which has the advantages of strong pertinence, good curative effect, non-toxic side effects, and convenient taking and carrying. Summary of the invention
  • the purpose of the present invention is to provide a new traditional Chinese medicine prescription for treating irritable bowel syndrome.
  • the medicine has definite effect on diarrhea-type irritable bowel syndrome, has small side effects, good safety, and is convenient to take and carry.
  • Another object of the present invention is to provide a new traditional Chinese medicine preparation prepared by the formula.
  • Another object of the present invention is to provide a method for preparing the above-mentioned traditional Chinese medicine preparation.
  • the raw materials with the following weight ratios are provided: 1 part of peppermint oil and 80-180 parts of white peony / red peony.
  • the weight ratio of the drug substance contained in the Chinese herbal medicine formula of Shangmi is: 1 part of lutein oil and 100-160 parts of white peony / red peony. Further preferred weight ratio is: 1 part of peppermint oil and 130 parts of white peony / red peony.
  • the Chinese medicinal preparation according to the present invention is obtained by mixing an extract obtained by treating white peony / red peony with a conventional extraction method and 1 part of peppermint oil.
  • the above extract is an extract powder obtained by water extraction and purification.
  • the traditional Chinese medicine preparation according to the present invention is preferably a tablet, a hard gel liniment or a soft gel liniment.
  • the above-mentioned traditional Chinese medicine preparation for treating irritable bowel syndrome may also contain medicinal excipients required for preparing different dosage forms of medicines, such as lubricants such as magnesium stearate, talc, and polymer when preparing tablets or hard capsules.
  • lubricants such as magnesium stearate, talc, and polymer when preparing tablets or hard capsules.
  • Glycols, etc. fillers such as starch, dextrin, sucrose, lactose, mannitol, calcium sulfate, etc., disintegrating agents such as microcrystalline cellulose, low-substituted hydroxypropyl cellulose, etc., binders such as Ethylcellulose, povidone, hydroxypropylmethylcellulose, sodium carboxymethylcellulose, gelatin, ethanol, modified starch, etc.
  • Paeonia lactiflora / paeonia lactiflora in the method for preparing a Chinese medicinal preparation according to the present invention can be extracted by conventional methods, for example, water extraction method, organic solvent extraction method, supercritical extraction method and the like.
  • the white peony / red peony is extracted and purified with water to obtain an extract powder. It includes the following steps:
  • Extracting white peony / red peony take the white peony or red peony medicinal materials in the proportion, add 6 to 10 times the amount of water to cook and extract 2-4 times, each time for 3 hours, filter, and filter the combined filtrate Concentrated to a relative density of about 1. 10-1. 20, adding 2-4 times the amount of an 80-95% ethanol solution, standing the precipitate for 12-48 hours, filtering, recovering the filtrate to ethanol and concentrating to a relative density of about 1. 10 -1.
  • the content of paeoniflorin in the peony / red peony extract powder obtained in the above step (1) can reach more than 30% (g / g).
  • other methods can be used to further refine it.
  • the dosage form of the Chinese medicine for treating irritable bowel syndrome is more preferably a soft gel tincture, which consists of a soft gel tin content containing the above-mentioned peppermint oil and white tincture / red tincture extract powder and a soft gel tin covering the surface
  • the shell composition; and the contents of the soft gum tincture also contain any one or more medicinal excipients selected from vegetable oil, soybean phospholipids, beeswax, glycerin, polyethylene glycol, propylene glycol, and isopropanol; Contains gelatin, glycerin and water.
  • the soft gelatin shell can also contain sorbic acid, acrylic resin II, acrylic resin III, water, titanium dioxide, sodium hydroxide, sucrose, ethyl paraben, paraben and propyl paraben. Any one or more.
  • the preferred components of the above soft gum tincture wherein the contents of the soft gum tincture contain the following weight ratio components: 1 part of peppermint oil, extract powder obtained from 100-160 parts of white tincture / red tincture, 1.5 -3 parts of soybean oil, 0.02-0.08 parts of soybean phospholipids, and 0.02-0.08 parts of beeswax; the components of the soft gelatin shell are: 3 parts gelatin, 1. 2-1. 8 parts glycerin, 0 ⁇ 6-1. 0 parts acrylic resin II, 0. 2- 0. 6 parts acrylic resin III, 0. 008- 0. 012 parts of paraben ethyl ester, 0. 18- 0. 24 parts sodium hydroxide, 2-3 parts of water.
  • the content of a further preferred soft gum tincture contains the following weight ratio components: 1 part of peppermint oil, extract powder obtained from 130 parts of white peony / red peony, 2.2 parts of soybean oil, 0.05 parts of soybeans Phospholipids and 0.05 Parts of beeswax; the components of the soft gum shell are: 3 parts of gelatin, 1.5 parts of glycerin, 0.8 parts of acrylic resin II, 0.4 parts of acrylic resin III, 0.01 parts of paraben ethyl ester, 0. 21 parts of sodium hydroxide, 2.5 parts of water.
  • an enteric film coating may be coated on the surface of the soft gelatin tincture to form an enteric soft gel tincture.
  • enteric coating materials there are many reviews in the literature and reports, commonly used and necessary ingredients ⁇ "Enteric acrylic resins such as domestic I, II, III, respectively, are equivalent For imported Eudragit t L30D, L100D, S100, this kind of material does not dissolve in gastric juice, but dissolves into salt in intestinal fluid with higher pH value; among them, widely used are II, III (commonly used a certain proportion of their mixture );
  • some cellulose derivatives such as hydroxypropyl fluorenyl cellulose, ethyl cellulose, propyl cellulose, and polyvinylpyrrolidone can be optionally added.
  • the above materials are commercially available.
  • the preparation method of the traditional Chinese medicine soft tincture for treating irritable bowel syndrome includes the following steps:
  • Extracting white scallion / red scallion take the ratio of white scallion or scallion medicinal materials, add 6-10 times the amount of water to decoction and extract 2 to 4 times, each time 1-3 hours, after ⁇ , combine the filtrate And concentrated the filtrate to a relative density of about 1.10-1.20, added 2-4 times the amount of an 80-95% ethanol solution, left the precipitate for 12-48 hours, filtered, recovered the filtrate and concentrated the ethanol to a relative density About 1. 10- 1. 20, add equal amounts
  • an enteric-type film coating can also be coated on the surface of the soft gelatin capsules prepared above according to a conventional coating process to form an enteric soft gelatin capsule.
  • the menthol oil mentioned in the present invention is a volatile oil obtained from fresh stems or leaves of Labiatae mint (Mentha haplocalyx Bi-iq.) After being steam-steamed, frozen, and partially de-brained, namely Chinese Pharmacopoeia 2000 A contained mint oil. Its quality should comply with Chinese Pharmacopoeia standards: the total alcohol content is calculated according to menthol (d. H 2.0 ), and it should not be less than 50.0% (g / g).
  • Peppermint oil can be purchased from legal API manufacturers, or it can be prepared from the Chinese herbal medicine peppermint according to the method described above.
  • the white peony / red peony refers to white peony, red peony, or a mixture of white peony and red peony.
  • the Paeonia lactiflora referred to in the present invention is processed from the roots of Paeonia lactiflora Pall., And the processing method is as follows: after removing the head and tail and the fibrous roots, scrape off the skin, and cook in boiling water until thoroughly Remove the heart, soak it in cold water, and take it out for drying (or cook it first, then scrape the skin, and then dry it);
  • the red scallion mentioned in the present invention is Paeonia lactiflora Pall. Or Sichuan red Dried root of Paeonia (Paeonia veitchii Lynch.).
  • paeonia lactiflora C i U must not be less than 0.80% (g / g)
  • paeoniflorin C 23 H 2S 0 u
  • red peony must not be less than 1.80% (g / g).
  • the beneficial effects of the present invention are: (1).
  • Chinese patent medicine the invention uses for the first time a scientific formula of peppermint oil and paeonia lactiflora / red peony as a raw material medicine, and is composed of a certain weight ratio. It has been proven by animal tests and clinical trials to have liver relieving depression, analgesic and anti-inflammatory properties. The effects such as regulating qi and stopping diarrhea are used for prevention and treatment of diarrhea-type irritable bowel syndrome, and the effect is precise; especially the optimized formula has particularly excellent effect.
  • the menthol oil and paeonia lactiflora and radix paeoniae in the medicine of the present invention are commonly used traditional Chinese medicines, and have been proven by pharmacological and toxicological tests to have small toxic and side effects, good safety, and low cost. The cost of treatment is low.
  • Menthol oil mainly contains menthol (Menthol, 40-60%), menthol (Menthone) and other ingredients: It has the effects of expelling wind, regulating qi, depressing, anti-inflammatory, analgesic, etc. It has the effects of excitement, anti-vomiting and anti-depression.
  • the main components of Paeonia lactiflora and Paeonia lactiflora are Paeoniflorin, which have good effects of dilating blood vessels, analgesic and sedative, anti-inflammatory and anti-ulcer, antipyretic and spasm, and diuretic.
  • the medicament of the present invention combines peppermint oil with paeonia lactiflora and paeonia lactiflora in a scientific combination, and plays a role in relieving liver and stagnation, analgesic and anti-inflammatory, and regulating qi and diarrhea.
  • the medicament of the present invention made with different drug substance ratios is homemade and diluted with edible oil.
  • the positive control drug Yimengling (Luobutamide hydrochloride) was a product of Xi'an Yangsen Pharmaceutical Co., Ltd.
  • the rats were randomly divided into 8 groups of 8 rats each, namely the blank control group (injected with edible oil Iml / lOOg), the positive drug group (2 mg / kg Yimeng stop), peppermint oil, and peony / red
  • the composition ratio of the drug substance is 1: 100 (white peony), 1: 130 (white peony), 1: 160 (white peony), 1: 130 (red peony).
  • a peppermint oil group ( ⁇ 5 group) and a white) group ( ⁇ 6 group are prepared according to the method for extracting white ⁇ / red ⁇ in the present invention). 10 times of the intended clinical dose was administered orally once a day for 6 consecutive days.
  • a diarrhea model of irritable bowel syndrome (IBS) in rats with restraint stress was made. See Table 1:
  • Each group of the medicine of the present invention can significantly prolong the incubation period of diarrhea caused by castor oil in rats, significantly reduce the cumulative number of diarrhea, and the effect can be maintained to a minimum of 2 hours after the medicine; the effect of reducing the loose stool rate can be maintained to 6 hours after the medicine. Compared with the blank group, the difference is significant (P ⁇ 0.05).
  • the results are shown in Tables 2 and 3.
  • the medicine of the present invention has an inhibitory effect on diarrhea model of irritable bowel syndrome in rats caused by castor oil,
  • the effect of peppermint oil alone or paeony is better, and it is equivalent to that of the positive control drug Yimeng stop, suggesting that this product has a good effect in treating irritable bowel syndrome.
  • test results are as follows:
  • the toxicity of peppermint oil is very low, and LD 5 cannot be detected when given by gavage.
  • mice by intravenous injection and intraperitoneal injection of Paeonia lactiflora extract (prepared according to the method of extracting Paeonia lactiflora / Red paeony in the preparation method of the present invention, the same applies hereinafter).
  • Paeonia lactiflora extract prepared according to the method of extracting Paeonia lactiflora / Red paeony in the preparation method of the present invention, the same applies hereinafter.
  • 159mg / kg (equivalent to approximately 12.2g / kg of raw medicinal materials)
  • 230mg / kg equivalent to approximately of raw medicinal materials)
  • mice Feeding mice with paeony extract about 3000 mg / kg (equivalent to about 230g / kg of raw medicinal materials), no obvious symptoms of poisoning and no death.
  • the results of chronic toxicology studies showed that: it has no obvious toxicity to important organs of mice. Rats and dogs were given 3 different doses of Paeonia lactiflora extract (50 mg / kg, 1,000 mg / kg, 2000 mg / kg per day, equivalent to 5 to 200 times the highest adult dose) for 30 and 90 days. No obvious toxic damage, indicating that the drug has low toxicity and a large safety range.
  • Red peony extract prepared according to the method for extracting white peony / red peony in the medicine preparation method of the present invention
  • the maximum tolerated amount for intravenous injection in mice is greater than 50g / kg (raw medicine), and the maximum tolerated for mice by intragastric administration The amount is greater than 280 g / kg (raw herbs).
  • Fiber colonoscopy is normal, some patients have hyperkinesia, increased mucus, no obvious mucosal abnormalities, and histological examination is basically normal.
  • the treatment group was administered the drug of the present invention (the raw drug composition of the drug is: 100g of peppermint oil, 13000g of white peony, 220g of soybean oil, 5g of soybean phospholipid, 5g of beeswax, and 1000 soft capsules were made) Oral, 3 times a day, 2 capsules / time; the control group was given an equal dose of soft gelatin made of monomenthol oil, orally, 3 times a day, 2 capsules / time, the course of treatment was 1 month.
  • the raw drug composition of the drug is: 100g of peppermint oil, 13000g of white peony, 220g of soybean oil, 5g of soybean phospholipid, 5g of beeswax, and 1000 soft capsules were made
  • Oral 3 times a day, 2 capsules / time
  • the control group was given an equal dose of soft gelatin made of monomenthol oil, orally, 3 times a day, 2 capsules / time, the course of treatment was 1 month.
  • Points ratio points before treatment-points after treatment X 100%
  • the present invention is the pharmaceutical treatment of irritable bowel syndrome (diarrhea type) of the total effective rate was 95% efficacy alone and peppermint oil has a significant statistical difference compared. It shows that the medicine of the present invention has obvious therapeutic effect on irritable bowel syndrome (diarrhea type).
  • Example one is a hard gum tincture, and the raw material components of the contents of the gum tincture are: 1 part of peppermint oil and 130 parts of white tincture.
  • Extracting Paeonia lactiflora Take the medicinal materials of Paeonia lactiflora and add 10 times the amount of water to decoction and extract 4 times for 2 hours each time, filter, combine the filtrates, and concentrate the filtrates to a relative density of about 1.10, add 2 An 80% ethanol solution was doubled, and the precipitate was left standing for 12 hours, filtered, and the filtrate was recovered to ethanol and concentrated to a density of about 1.10.
  • This example is an enteric hard gelatin tincture.
  • the raw material ingredients of the gelatin capsule are: 1 part of peppermint oil, 160 parts of white tincture, and 0.01 part of magnesium stearate.
  • An enteric hard gel tincture is prepared by a method that includes the following steps:
  • Extracting Paeonia lactiflora Take the ratio of Paeonia lactiflora and add 6 times the amount of water to decoction to extract 3 Huan, each 3 hours, filter, combine the filtrate, and concentrate the filtrate to a relative density of about 1.20, add 4 Double the amount of 95% ethanol solution, leave it to stand for 48 hours, and filter. The filtrate is recovered and concentrated to a mesh density of about 1.20. An equal amount of 0.2mol / L NaHC0 3 solution is added. Stir to dissolve. Add 5 times the amount.
  • This embodiment is an enteric hard gelatin tincture.
  • the raw material ingredients of the gelatin capsule are: 1 part of mint t oil and 80 parts of red tincture.
  • An enteric hard gel tincture is prepared by a method that includes the following steps:
  • Extracting red scallion Take the red scallion medicinal materials with the proportion and add 8 times the amount of water to cook and extract 2: twice for 1 hour each time, filter, combine the filtrates, and concentrate the filtrates to a relative density of about 1.15, add 3 times the amount of 85% ethanol solution, left standing for 16 hours, filtered, the filtrate was recovered ethanol and concentrated to a mesh density of about 1.15, the same amount of 0.2mol / L NaHC0 3 solution was added, stirred to dissolve, added 4 times the amount Extract 3 times with ethyl acetate, combine the ethyl acetate extracts, recover the ethyl acetate to near dryness, add 5 times the amount of 75% ethanol solution to dissolve, filter, then recover the filtrate to ethanol and concentrate to a relative density of about 1.10, spray Dried to obtain red chrysalis extract powder;
  • This embodiment is a film-coated tablet, and the raw material components of the core are: 1 part of peppermint oil, 180 parts of white peony, and 5 parts of corn starch.
  • Tablets are made by a method that includes the following steps:
  • Extracting Paeonia lactiflora Take the medicinal materials of Paeonia lactiflora and add 7 times the amount of water to decoction and extract 3 times, 3 hours for the first time, 1.5 hours for the second and third times, filter, combine the filtrates, and The filtrate was concentrated to a relative density of about 1.15, 3 times the amount of a 90% ethanol solution was added, and the precipitate was left to stand for 18 hours, filtered, the filtrate was recovered to ethanol and concentrated to a relative density of about 1.15, and an equal amount of a 0.2mol / L NaHC0 3 solution was added.
  • This embodiment is an enteric film-coated tablet.
  • the raw material components of the tablet core are: 1 part of peppermint oil and 100 parts of red pepper.
  • Tablets are made by a method that includes the following steps:
  • Extracting red scallion Take the red scallion medicinal materials with the proportion, add 9 times the amount of water to cook and extract twice, 1.5 hours each time, filter, combine the filtrates, and concentrate the filtrates to a relative density of about 1.18, add 4 90% ethanol solution, settle for 24 hours, and filter. The filtrate was recovered and concentrated to a relative density of about 1.15. An equal amount of 0.2mol / L NaHC0 3 solution was added, stirred to dissolve, and 5 times the amount of acetic acid was added.
  • Extract twice with ethyl acetate combine the ethyl acetate extracts, recover the ethyl acetate to near dryness, add 3 times the amount of 80% ethanol solution to dissolve, filter, and then recover the filtrate to ethanol and concentrate to a relative density of about 1.15, spray-dried To get red chrysanthemum extract powder;
  • This embodiment is a soft gel tincture, where:
  • the drug substance components of the contents of the soft gum tincture are: 1 part of peppermint oil, 150 parts of white tincture, and 2.6 parts of tea oil.
  • the soft film is composed of the following weight ratio components: 3 parts of gelatin, 1 part of glycerin, 0.09 part of paraben, 1.6 parts of water.
  • This embodiment is a soft gel tincture, where:
  • the drug substance components of the contents of the soft capsules are: 1 part of peppermint oil, 140 parts of peony, 2.4 parts of soybean oil, 0.07 parts of soybean phospholipids, and 0.03 parts of beeswax.
  • the soft film is composed of the following weight ratio components: 3 parts gelatin, 1.5 parts glycerin, 1 part water. Make a soft gel tincture by a method that includes the following steps:
  • Extracting white peony take the ratio of white peony, add 10 times the amount of water to cook and extract 4 times, 2 hours each time, filter, combine the filtrate, and concentrate the filtrate to a relative density of about 1. 20, 3 times the amount of 85% ethanol solution was added, and the precipitate was allowed to stand for 36 hours, filtered, and the filtrate was recovered into ethanol and concentrated to a relative amount.
  • Density is about 1.12, add an equal amount of 0.2mol / L NaHC0 3 solution, stir to dissolve, add 5 times the amount of ethyl acetate to extract twice, combine the ethyl acetate extracts, recover the ethyl acetate to near dry, and then add 2 times The amount of 85% ethanol solution was dissolved, filtered, and then the filtrate was recovered ethanol and concentrated to a relative density of about 1.18, and spray-dried to obtain Baiji extract powder;
  • This embodiment is a soft gel tincture, where:
  • the drug substance components of the contents of the soft capsules are: 1 part of peppermint oil, 130 parts of peony, 2.2 parts of soybean oil, 0.05 parts of soybean phospholipids, and 0.05 parts of beeswax.
  • the soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.5 parts of glycerin, 0.8 parts of acrylic resin II, 0.4 parts of acrylic resin III, 0.01 parts of paraben ethyl ester, 0.21 parts of sodium hydroxide, 2.5 parts of water.
  • Extracting Paeonia lactiflora Take the medicinal materials of Paeonia lactiflora and add 8 times the amount of water to decoction and extract it twice, the first time is 2 hours, and the second time is 1 hour. Filter, combine the filtrates, and concentrate the filtrates to The relative density is about 1, 15, 3 times the amount of 85% ethanol solution is added, the precipitate is left for 16 hours, filtered, the filtrate is recovered ethanol and concentrated to a relative density of about 1.15, and an equal amount of a 0.2mol / L NaHC0 3 solution is added.
  • This embodiment is a soft gel tincture, where:
  • the drug substance components of the contents of the soft capsule are: 1 part of peppermint oil, 100 parts of red pepper, 2.4 parts of soybean oil, 0.07 parts of soybean phospholipid, and 0.03 parts of beeswax.
  • the soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.8 parts of glycerin, 0.9 parts of acrylic resin II, 0.5 parts of acrylic resin III, 0.09 parts of paraben ethyl ester, 0. 20 parts sodium hydroxide, 2.6 parts water.
  • Extracting red scallion take the ratio of red scallion medicinal materials, add 6 times the amount of water to cook and extract 4 times, 1.5 hours each time, filter, combine the filtrates, and concentrate the filtrate to a relative density of about 1. 12, add 4 times the amount of 80% ethanol solution, leave the precipitate for 12 hours, filter, recover the filtrate and concentrate the ethanol to a relative density of about 1.
  • This embodiment is a soft gel tincture, where:
  • the drug substance components of the contents of the soft capsule are: 1 part of peppermint oil, 160 parts of peony, 3 parts of soybean oil, 0.02 parts of soybean phospholipid, and 0.02 parts of beeswax.
  • the soft film is composed of the following weight ratio components: 3 parts of gelatin, 2.4 parts of glycerin, 0.6 parts of acrylic resin II, 0.3 parts of acrylic resin III, 0.008 parts of paraben propyl, 0. 24 parts of sodium hydroxide, 2.4 parts of water.
  • This embodiment is a soft gel tincture, where:
  • the drug substance components of the contents of the soft capsule are: 1 part of peppermint oil, 120 parts of peony, 2 parts of soybean oil, 0.03 parts of soybean phospholipid, and 0.08 parts of beeswax.
  • the soft film is composed of the following weight ratio components: 3 parts of gelatin, 0.8 parts of glycerin, 0.7 parts of acrylic resin II, 0.6 parts of acrylic resin III, 0.011 parts of paraben ethyl ester, 0. 18 parts of sodium hydroxide, 1 part of water.
  • the glue solution is made into a soft film with uniform thickness and a certain elasticity according to a conventional process for use;
  • Embodiment 12 This embodiment is an enteric soft gel liniment, where:
  • the drug substance components of the contents of the soft gum tincture are: 1 part of peppermint oil, 180 parts of peony, 1.5 parts of soybean oil, 0.08 parts of soybean phospholipids, and 0.007 parts of beeswax.
  • the soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.2 parts of glycerin, 1 part of acrylic resin II, 0.2 parts of acrylic resin III, 0.012 parts of paraben ethyl ester, 0.18 parts Sodium hydroxide, 3 parts of water.
  • the surface of the preparation is also coated with an enteric film coating.
  • An enteric soft gel tincture is prepared by a method that includes the following steps:
  • the glue solution is made into a thin film with a uniform thickness and a certain elasticity according to a conventional process for use;
  • This embodiment is an enteric soft gel liniment, where:
  • the drug substance components of the contents of the soft capsule are: 1 part of peppermint oil, 80 parts of red pepper, 2.2 parts of peanut oil, 0. 05 parts of soybean phospholipid, Q. 05 parts of beeswax.
  • the soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.5 parts of glycerin, 0.8 parts of acrylic resin II, 0.4 parts of acrylic resin III, 0.01 parts of paraben ethyl ester, 0. 21 parts sodium hydroxide, 2.5 parts water.
  • the surface of the preparation is also coated with an enteric film coating.
  • An enteric soft gel tincture is prepared by a method that includes the following steps:
  • Extracting red scallion take the ratio of red scallion medicinal materials, add 9 times the amount of water to cook and extract twice, the first 2.5 hours, the second 1.5 hours, filter, combine the filtrates, and Lmol
  • the filtrate was concentrated to a relative density of about 1.17, 4 times the amount of 80% ethanol solution was added, the precipitate was left for 32 hours, filtered, the filtrate was recovered ethanol and concentrated to a relative density of about 1.17, and an equal amount of 0.1 lmol was added.
  • the glue solution is made into a soft film with a uniform thickness and a certain elasticity according to a conventional process.
  • enteric soft gelatin capsules Made of enteric soft gelatin capsules: The contents of the soft gelatin capsules and the soft capsules on a soft capsule press are pressed into a soft gel capsule of 0.5g / granule, and then the surface is coated with a conventional coating process for one An enteric film coating is sufficient.
  • This embodiment is a soft gum tincture, wherein: the raw material medicine components of the soft gum tincture are: 1 part of peppermint oil, 100 parts of peony, 2.5 parts of soybean vegetable oil, 0.1 part of soybean phospholipid, 0.1 Portions of beeswax.
  • the soft film is composed of the following weight ratio components: 3 parts gelatin, 1.5 parts glycerin, 1 part water.
  • step (2) taking the ratio of soybean vegetable oil, heating it to about 55 ° C, adding the ratio of soybean phospholipid and beeswax, dissolving and mixing the mixture, adding the ratio of mint oil, and mixing, Add the Paeonia lactiflora powder obtained in step (1) while stirring, and continue to stir for about 30 minutes after the addition is complete, so that the mixture is homogeneous, and let stand for more than 12 hours for use;
  • This embodiment is a soft gel tincture, where:
  • the drug substance components of the contents of soft capsules are: 1 part of peppermint oil, 80 parts of peony, 2.0 parts of soybean vegetable oil, and 0.1 part of beeswax.
  • the soft film is composed of the following weight ratio components: 3 parts gelatin, 1.6 parts glycerin, 0.9 parts water. Preparation:
  • This embodiment is a soft gel tincture, where:
  • the drug substance components of the contents of soft capsules are: 1 part of peppermint oil, 130 parts of red pepper, 3 parts of soybean plant Oil.
  • the soft film consists of the following weight ratio components: 3 parts gelatin, 1.2 parts glycerin, 0.5 parts water. Preparation:
  • step (2) Take the proportion of soybean vegetable oil, heat it to about 55 ° C, add the proportion of menthol oil, mix well, and then add the red scallion extract powder obtained in step (1) while stirring, Continue to stir for about 30 minutes after the addition is complete, make the mixture uniform, and let it stand for more than 12 hours;
  • This embodiment is a soft gel tincture, where:
  • the drug substance components of the contents of soft capsules are: 1 part of peppermint oil, 160 parts of red pepper, 2.8 parts of soybean vegetable oil.
  • the soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.2 parts of glycerin, 0.5 parts of water, 0.01 parts of paraben ethyl ester.
  • step (2) taking the proportion of soybean vegetable oil, heating it to about 55 ° C, adding the proportion of menthol oil, mixing well, and then adding the red chrysanthemum extract powder obtained in step (1) while stirring, Continue to stir for about 30 minutes after the addition is complete, make the mixture uniform, and let it stand for more than 12 hours;
  • Embodiment 18 This embodiment is a soft gel tincture, where:
  • the drug substance components of the contents of soft capsules are: 1 part of peppermint oil, 180 parts of red peony, and 2 parts of soybean vegetable oil.
  • the soft film is composed of the following weight ratio components: 3 parts gelatin, 1.2 parts glycerin, 0.5 parts water, 0.02 parts sorbic acid.
  • step (2) taking the proportion of soybean vegetable oil, heating it to about 55 ° C, adding the proportion of menthol oil, mixing well, and then adding the red chrysanthemum extract powder obtained in step (1) while stirring, Continue to stir for about 30 minutes after the addition is complete, make the mixture uniform, and let it stand for more than 12 hours;
  • This embodiment is a soft gel tincture, where:
  • the drug substance components of the contents of soft capsules are: 1 part mint oil, 100 parts white peony, 80 parts red peony,
  • the soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.2 parts of glycerin, 0.4 parts of water, 0.01 parts of paraben.
  • step (2) Take the proportion of soybean vegetable oil, heat it to about 55 ° C, add the proportion of menthol oil, mix well, and then add the chitin extract powder obtained in step (1) while stirring, Continue to stir for about 30 minutes after the addition is complete, make the mixture uniform, and let it stand for more than 12 hours;
  • the pharmaceutical excipients used in the above examples were purchased from legal excipient manufacturers, among which: magnesium stearate is a product of Shanghai Yuanji Chemical Co., Ltd .; corn starch is a product of Zhenyu Huanyu Pharmaceutical Excipients Factory in Jiangsu; gelatin is Qinghai Products of Gelatin Co., Ltd .; glycerin is a product of Hangzhou Asia-Pacific Chemical Equipment Co., Ltd .; paraben, ethyl paraben and ethyl paraben are products of Xinke Chemical Co., Ltd.
  • the enteric film coating used in each of the above examples was an enteric film coating premix obtained from Chengdu Taishan Film Coating Factory.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a Chinese medicine treating irritable bowel syndrome, which comprises Pennyroyal and Radix Paeoniae Alba or Radix Paeonia Rubra in a ratio of 1:80-180. It is effective. The present invention also discloses the preparation method thereof.

Description

一种治疗肠易激综合征的中药及其制备方法 技术领域  Traditional Chinese medicine for treating irritable bowel syndrome and preparation method thereof
本发明涉及药物制剂领域, 具体地说涉及一种治疗肠易激综合征的中药 及其制备方法。 背景技术  The invention relates to the field of pharmaceutical preparations, in particular to a traditional Chinese medicine for treating irritable bowel syndrome and a preparation method thereof. Background technique
肠易激综合征(Irr i table Bowel Syndrome, IBS)是胃肠道最常见的功能 性疾病,指的是一组包括腹痛、 腹胀、 排便习惯和大便性状异常、 粘液便,持 续存在或反复发作,而又缺乏形态学和生化学异常改变可资解释的症状群。 西 方统计约占消化科病人的 20% ~ 40%,国内统计约占消化道门诊患者的  Irritable bowel syndrome (IBS) is the most common functional disorder of the gastrointestinal tract. It refers to a group including abdominal pain, bloating, abnormal bowel habits and stool characteristics, mucus, persistent or recurrent , And lack of morphological and biochemical abnormalities can explain the symptom group. Western statistics account for about 20% to 40% of patients in the digestive department, and domestic statistics account for about 20% of outpatients in the digestive tract.
13%- 52%。 但是对肠易激综合征的病因和发病机制至今还不完全清楚, 其治疗 的目的主要是消除患者的顾虑, 改善症状, 提高生活质量。 13%-52%. However, the etiology and pathogenesis of irritable bowel syndrome are not fully understood so far, and the main purpose of its treatment is to eliminate patients' concerns, improve symptoms, and improve quality of life.
在化学药方面, 目前临床常用有关肠易激综合征治疗药物的研究分为两 方面: 一方面是终末器官治疗, 主要是针对特异性症状; 另一方面是中枢治 疗, 主要是通过药物干预中枢神经系统特异性的神经传导而消除肠易激综合 征的症状。 终末器官治疗的药物有洛哌丁胺、 苯乙哌叮、 纳洛酮等; 中枢治 疗的药物如抗抑郁症和抗焦虑药等。 以上各类药物虽能緩解肠易激综合征的 某些症状, 但在应用中存在着无法根治, 副作用大, 个体差异明显, 治疗费 用高等缺点。  In terms of chemical drugs, the current clinical research on drugs for the treatment of irritable bowel syndrome is divided into two aspects: on the one hand, terminal organ treatment, mainly for specific symptoms; on the other hand, central treatment, mainly through drug intervention Central nervous system-specific nerve conduction eliminates symptoms of irritable bowel syndrome. Drugs for terminal organ treatment include loperamide, phenebutene, and naloxone; drugs for central treatment, such as antidepressants and anxiolytics. Although the above types of drugs can alleviate some symptoms of irritable bowel syndrome, there are disadvantages in the application that cannot be cured, side effects are large, individual differences are obvious, and treatment costs are high.
在中医药方面, 传统中医将肠易激综合征归属于泄泻、 便秘、 腹痛、 滞 下、 郁证、 瘕聚、 肠擗等范畴, 认为它可由外感邪气, 内伤饮食情志, 素体虚 弱, 年老久病, 劳倦过度等原因引起, 临床上常见肝郁、 脾虚、 肾虚、 积滞、 血瘀等证,且多有兼杂之证, 而又偏重不同。 根据不同的分类法可将其分为两 种、 三种或八种证型, 通常分为腹泻型、 便秘型、 混合型三型, 其中又以腹 泻型最为常见。 传统中药在治疗肠易激综合征中显示了良好的前景, 如浙江 中西医结合杂志 2002年第 12卷第 2期有 《中药治疗肠易激综合征 56例》, 江苏中医 2000年第 21卷笫 5期有《中药治疗肠易激综合征 47例》等。 在中 医治则方面, 以疏肝健脾、 理气温腎最为常用; 其次为清热、 祛瘀、 滋阴、 活血等。 也有采用针灸、 按摩、 穴位注射、 电刺激、 外敷药饼等方法治疗的 报道, 但其操作很不方便, 患者多需到有条件的医疗单位进行, 或者影响患 者的行动, 这在很大程度上限制了它的临床应用。 对于腹泻型肠易激综合征, 属 "泻泄" 范畴, 多因肝气郁结、 肝失疏泄、 肝木乘脾而致脾失健运, 多兼 有肝郁与脾虚症状, 其治疗以疏肝解郁、 健脾益气为主。 临床常用的中药方 剂如痛泻要方、 参苓白术散、 半夏泻心汤、 小青龙汤等虽能随症加减, 但它 们为汤剂, 在携带、 服用等方面都很不方便, 煎药过程耗时较长, 尤其对于 腹泻型患者, 因多为急证往往易延误病情, 而且口感不好, 患者的依从性也 差; 此外, 如果是给患者自己煎药, 不仅很不方便, 还会因其操作不当等原 因造成疗效欠佳。 在中成药方面, 常用的有补脾益肠丸、 藿香正气水、 藿香 正气液、 藿香正气软胶囊、 藿香正气滴丸等, 但这些药物均不是主要针对肠 易激综合征而开发的产品, 在治疗上述肠易激综合征时疗效还不是非常理想。 In traditional Chinese medicine, traditional Chinese medicine classifies irritable bowel syndrome in the categories of diarrhea, constipation, abdominal pain, stagnation, depression, gathering, intestinal dysfunction, etc. It is believed that it can be caused by exogenous evil qi, internal injury diet, and weak body. Caused by chronic diseases, overwork and other causes, liver stagnation, spleen deficiency, kidney deficiency, stasis, blood stasis and other syndromes are common clinically, and there are many mixed syndromes, but they have different emphasis. According to different classifications, it can be divided into two, three or eight syndrome types, which are usually divided into diarrhea type, constipation type and mixed type three types, among which the diarrhea type is the most common. Traditional Chinese medicine has shown good prospects in the treatment of irritable bowel syndrome. For example, Zhejiang Journal of Integrated Traditional Chinese and Western Medicine 2002, Vol. 12, No. 2, "Traditional Chinese Medicine for 56 Cases of Irritable Bowel Syndrome", Jiangsu Traditional Chinese Medicine, Volume 21 Stage 5 includes "Traditional Chinese Medicine for 47 Cases of Irritable Bowel Syndrome" and so on. In terms of traditional Chinese medicine, the most commonly used methods are to clear the liver, strengthen the spleen, and treat the temperature and kidneys; followed by clearing heat, removing stasis, nourishing yin, and activating blood. There have also been reports of acupuncture, massage, acupoint injection, electrical stimulation, topical cakes and other methods of treatment, but the operation is very inconvenient, and patients often need to go to a qualified medical unit, or affect the patient's actions, which is to a large extent It has limited its clinical application. For diarrhea-type irritable bowel syndrome, it belongs to the category of "diarrhea". It is caused by liver qi stagnation, liver loss, liver stasis, and spleen. There are symptoms of liver stagnation and spleen deficiency, and the main treatments are to relieve liver stagnation and relieve spleen and strengthen spleen. Although the commonly used traditional Chinese medicine prescriptions such as Tongxie Yaofang, Shenling Baizhu Powder, Banxia Xiexin Decoction, Xiaoqinglong Decoction can be added and subtracted according to the symptoms, they are decoctions, which are very inconvenient in carrying and taking. The decoction process takes a long time, especially for patients with diarrhea. Because of the urgent symptoms, the disease is often delayed, and the taste is not good, and the patient's compliance is poor. In addition, if the decoction is given to the patient, it is not only inconvenient. , Also because of its improper operation and other reasons cause poor efficacy. In terms of proprietary Chinese medicines, Bupi Yichang Pills, Huoxiangzhengqi Water, Huoxiangzhengqi Liquid, Huoxiangzhengqi Soft Capsules, Huoxiangzhengqi Dropping Pills, etc. are commonly used, but these drugs are not mainly aimed at irritable bowel syndrome. The developed products are not very effective in treating the above-mentioned irritable bowel syndrome.
因此, 本发明旨在提供一种新的治疗肠易激综合症的中药, 其具有针对 性强, 疗效好、 无毒副作用及服用和携带都方便等优点。 发明内容  Therefore, the present invention aims to provide a new Chinese medicine for treating irritable bowel syndrome, which has the advantages of strong pertinence, good curative effect, non-toxic side effects, and convenient taking and carrying. Summary of the invention
本发明的目的就是提供一种新的治疗肠易激综合征的中药组方, 该药物 对于腹泻型肠易激综合征疗效确切, 副作用小, 安全性好, 且服用和携带都 很方便。  The purpose of the present invention is to provide a new traditional Chinese medicine prescription for treating irritable bowel syndrome. The medicine has definite effect on diarrhea-type irritable bowel syndrome, has small side effects, good safety, and is convenient to take and carry.
本发明的另一个目的是提供一种新的由该组方制得的中药制剂。  Another object of the present invention is to provide a new traditional Chinese medicine preparation prepared by the formula.
本发明的另一个目的是提供一种制备上述中药制剂的方法。  Another object of the present invention is to provide a method for preparing the above-mentioned traditional Chinese medicine preparation.
按本发明的中药组方, 舍有以下重量配比的原料药: 1份薄荷素油和 80-180份白芍 /赤芍。  According to the traditional Chinese medicine formula of the present invention, the raw materials with the following weight ratios are provided: 1 part of peppermint oil and 80-180 parts of white peony / red peony.
根据一个优选方案, 上迷中药组方中含有的原料药的重量配比为: 1份薄 荷素油和 100-160份白芍 /赤芍。进一步优选重量配比为: 1份薄荷素油和 130 份白芍 /赤芍。  According to a preferred solution, the weight ratio of the drug substance contained in the Chinese herbal medicine formula of Shangmi is: 1 part of lutein oil and 100-160 parts of white peony / red peony. Further preferred weight ratio is: 1 part of peppermint oil and 130 parts of white peony / red peony.
按本发明的中药制剂, 是由用常规提取方法处理白芍 /赤芍得到的提取物 与 1份薄荷素油混合而成。  The Chinese medicinal preparation according to the present invention is obtained by mixing an extract obtained by treating white peony / red peony with a conventional extraction method and 1 part of peppermint oil.
根据一个优选方案, 上 提取物是用水提取、 纯化得到的浸膏粉。  According to a preferred solution, the above extract is an extract powder obtained by water extraction and purification.
按本发明的中药制剂, 优选为片剂、 硬胶嚢剂或软胶嚢剂等。  The traditional Chinese medicine preparation according to the present invention is preferably a tablet, a hard gel liniment or a soft gel liniment.
上述治疗肠易激综合征的中药制剂中还可以含有为制备不同剂型的药物 所需要的药用辅料, 如制备片剂或硬胶嚢时可以加入润滑剂如硬脂酸镁、 滑 石粉、 聚乙二醇类物质等, 填充剂如淀粉类物质、 糊精、 蔗糖、 乳糖、 甘露 醇、 硫酸钙等, 崩解剂如微晶纤维素、 低取代羟丙基纤维素等, 粘合剂如乙 基纤维素、 聚维酮、 羟丙基甲基纤维素、 羧甲基纤维素钠、 明胶、 乙醇、 改 良淀粉等; 制备软胶嚢剂时 以加入各种植物油 (如大豆油、 茶油、 花生油 等)、 卵磷脂、 蜂蜡、 甘油、 聚乙二醇、 丙二醇、 异丙醇、 尼泊金酯系列等。 以上各种辅料均可从药用辅料生产厂家购买。 The above-mentioned traditional Chinese medicine preparation for treating irritable bowel syndrome may also contain medicinal excipients required for preparing different dosage forms of medicines, such as lubricants such as magnesium stearate, talc, and polymer when preparing tablets or hard capsules. Glycols, etc., fillers such as starch, dextrin, sucrose, lactose, mannitol, calcium sulfate, etc., disintegrating agents such as microcrystalline cellulose, low-substituted hydroxypropyl cellulose, etc., binders such as Ethylcellulose, povidone, hydroxypropylmethylcellulose, sodium carboxymethylcellulose, gelatin, ethanol, modified starch, etc. When preparing soft gel tinctures, various vegetable oils (such as soybean oil, tea oil, etc.) are added. , Peanut oil, etc.), lecithin, beeswax, glycerin, polyethylene glycol, propylene glycol, isopropyl alcohol, paraben ester series, etc. All the above excipients can be purchased from pharmaceutical excipient manufacturers.
按本发明的中药制剂的制备方法中的白芍 /赤芍可用常规方法提取, 例 如, 水提取法、 有机溶剂提取法, 超临界提取法等。  Paeonia lactiflora / paeonia lactiflora in the method for preparing a Chinese medicinal preparation according to the present invention can be extracted by conventional methods, for example, water extraction method, organic solvent extraction method, supercritical extraction method and the like.
根据一个优选方案, 用水提取、 纯化白芍 /赤芍, 得到浸膏粉。 具体包括 如下步骤:  According to a preferred solution, the white peony / red peony is extracted and purified with water to obtain an extract powder. It includes the following steps:
( 1 )提取白芍 /赤芍: 取所述配比的白芍或赤芍药材, 加入 6- 10倍量水 煎煮提取 2- 4次, 每次 3小时, 过滤, 并将合并的滤液浓缩至相对密度约 1. 10-1. 20, 加入 2-4倍量 80-95%的乙醇溶液, 静置沉淀 12-48小时, 过滤, 将滤液回收乙醇并浓缩至相对密度约 1. 10-1. 20, 加入等量的 0. 2mol/L的 NaHC03溶液, 搅拌使溶解, 加入 3- 5倍量乙酸乙酯萃取 2- 4次, 合并乙酸乙酯 萃取液, 回收乙酸乙酯至近干, 再加入 2-5倍量 75- 85%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并浓缩至相对密度约 1. 10- 1. 20, 喷雾干燥, 得白 芍 /赤芍浸膏粉; (1) Extracting white peony / red peony: take the white peony or red peony medicinal materials in the proportion, add 6 to 10 times the amount of water to cook and extract 2-4 times, each time for 3 hours, filter, and filter the combined filtrate Concentrated to a relative density of about 1. 10-1. 20, adding 2-4 times the amount of an 80-95% ethanol solution, standing the precipitate for 12-48 hours, filtering, recovering the filtrate to ethanol and concentrating to a relative density of about 1. 10 -1. 20, add an equal amount of 0.2mol / L NaHC0 3 solution, stir to dissolve, add 3-5 times the amount of ethyl acetate to extract 2 to 4 times, combine the ethyl acetate extracts, and recover ethyl acetate to near Dry, then add 2-5 times the amount of 75-85% ethanol solution to dissolve, filter, then recover the filtrate to ethanol and concentrate to a relative density of about 1. 10- 1. 20, spray-dried to obtain white 芍 / Red 芍 dipping Powder
( 2 )制成制剂: 取所述配比的薄荷素油, 与 (1 ) 步制得的白芍 /赤芍浸 膏粉混匀后按常规技术制成各种制剂。  (2) Preparation of preparations: Take the mentioned ratio of menthol oil and mix with the white scallion / red scallion extract powder prepared in step (1) to prepare various preparations according to conventional techniques.
其中, 上述(1 ) 步中提取制得的白芍 /赤芍浸膏粉中, 芍药苷的含量可 达到 30% (g/g)以上。 为了得到芍药苷含量更高的白芍 /赤芍浸膏粉, 还可逋过 其它方法进一步精制。  Among them, the content of paeoniflorin in the peony / red peony extract powder obtained in the above step (1) can reach more than 30% (g / g). In order to obtain Paeonia lactiflora / Red peony extract powder with higher paeoniflorin content, other methods can be used to further refine it.
上述治疗肠易激综合征的中药的剂型进一步优选为软胶嚢剂, 它由包含 上述薄荷素油和白芍 /赤芍的浸膏粉的软胶嚢内容物和覆在其表面的软胶嚢 壳构成; 且软胶嚢内容物中还含有选自植物油、 大豆磷脂、 蜂蜡、 甘油、 聚 乙二醇、 丙二醇和异丙醇等中的任意一种或几种药用辅料; 软胶嚢壳中含有 明胶、 甘油和水。  The dosage form of the Chinese medicine for treating irritable bowel syndrome is more preferably a soft gel tincture, which consists of a soft gel tin content containing the above-mentioned peppermint oil and white tincture / red tincture extract powder and a soft gel tin covering the surface The shell composition; and the contents of the soft gum tincture also contain any one or more medicinal excipients selected from vegetable oil, soybean phospholipids, beeswax, glycerin, polyethylene glycol, propylene glycol, and isopropanol; Contains gelatin, glycerin and water.
上述软胶嚢壳中还可以含有山梨酸、 丙烯酸树脂 II、 丙烯酸树脂 III、 水、 二氧化钛、 氢氧化钠、 蔗糖、 尼泊金乙酯、 尼泊金曱酯和尼泊金丙酯等中的 任意一种或几种。  The soft gelatin shell can also contain sorbic acid, acrylic resin II, acrylic resin III, water, titanium dioxide, sodium hydroxide, sucrose, ethyl paraben, paraben and propyl paraben. Any one or more.
上述软胶嚢剂的优选组分: 其中, 软胶嚢内容物中含有如下重量比的组 分: 1份薄荷素油、 由 100-160份白芍 /赤芍得到的浸膏粉、 1. 5-3份大豆油、 0. 02- 0. 08份大豆磷脂和 0. 02- 0. 08份蜂蜡; 软胶嚢壳的组分为: 3份明胶、 1. 2-1. 8份甘油、 0· 6-1. 0份丙烯酸树脂 II、 0. 2- 0. 6份丙烯酸树脂 III、 0. 008- 0. 012份尼泊金乙酯、 0. 18- 0. 24份氢氧化钠、 2- 3份水。  The preferred components of the above soft gum tincture: wherein the contents of the soft gum tincture contain the following weight ratio components: 1 part of peppermint oil, extract powder obtained from 100-160 parts of white tincture / red tincture, 1.5 -3 parts of soybean oil, 0.02-0.08 parts of soybean phospholipids, and 0.02-0.08 parts of beeswax; the components of the soft gelatin shell are: 3 parts gelatin, 1. 2-1. 8 parts glycerin, 0 · 6-1. 0 parts acrylic resin II, 0. 2- 0. 6 parts acrylic resin III, 0. 008- 0. 012 parts of paraben ethyl ester, 0. 18- 0. 24 parts sodium hydroxide, 2-3 parts of water.
进一步优选的软胶嚢剂的内容物中含有如下重量比的组分: 1份薄荷素 油、由 130份白芍 /赤芍得到的浸膏粉、 2. 2份大豆油、 0. 05份大豆磷脂和 0. 05 份蜂蜡; 软胶嚢壳的组分为: 3份明胶、 1. 5份甘油、 0. 8份丙烯酸树脂 II、 0. 4份丙烯酸树脂 III、 0. 01份尼泊金乙酯、 0. 21份氢氧化钠、 2. 5份水。 The content of a further preferred soft gum tincture contains the following weight ratio components: 1 part of peppermint oil, extract powder obtained from 130 parts of white peony / red peony, 2.2 parts of soybean oil, 0.05 parts of soybeans Phospholipids and 0.05 Parts of beeswax; the components of the soft gum shell are: 3 parts of gelatin, 1.5 parts of glycerin, 0.8 parts of acrylic resin II, 0.4 parts of acrylic resin III, 0.01 parts of paraben ethyl ester, 0. 21 parts of sodium hydroxide, 2.5 parts of water.
优选的是, 在上述软胶嚢表面上 可以包上一层肠溶型薄膜包衣, 以制 成肠溶软胶嚢剂。 肠溶型薄膜包衣的主要成份为肠溶包衣材料, 有很多综述 文献资料有报道, 常用且必需的成分^"肠溶型丙烯酸树脂类如国产 I号、 II 号、 III号, 分别相当于进口的 Eudragi t L30D、 L100D、 S100, 这类材料在胃 液中不溶解, 而在 PH值较高的肠液中成盐溶解; 其中应用广泛的是 II号、 III 号(常用其一定比例的混合物); 此外还可选择性的添加一些纤维素类衍生物 如羟丙基曱基纤维素、 乙基纤维素、 丙基纤维素, 以及聚乙烯吡咯烷酮类 物质等。 上述材料 可从市场购得。  Preferably, an enteric film coating may be coated on the surface of the soft gelatin tincture to form an enteric soft gel tincture. The main ingredients of enteric film coatings are enteric coating materials, there are many reviews in the literature and reports, commonly used and necessary ingredients ^ "Enteric acrylic resins such as domestic I, II, III, respectively, are equivalent For imported Eudragit t L30D, L100D, S100, this kind of material does not dissolve in gastric juice, but dissolves into salt in intestinal fluid with higher pH value; among them, widely used are II, III (commonly used a certain proportion of their mixture ); In addition, some cellulose derivatives such as hydroxypropyl fluorenyl cellulose, ethyl cellulose, propyl cellulose, and polyvinylpyrrolidone can be optionally added. The above materials are commercially available.
上述治疗肠易激综合征的中药软 嚢剂的制备方法, 包括如下步骤: The preparation method of the traditional Chinese medicine soft tincture for treating irritable bowel syndrome includes the following steps:
( 1 )提取白芍 /赤芍: 取所述配比的白芍或赤芍药材, 加入 6-10倍量水 煎煮提取 2- 4次, 每次 1-3小时, 过^ , 合并滤液, 并将滤液浓缩至相对密 度约 1. 10-1. 20, 加入 2-4倍量 80- 95%的乙醇溶液, 静置沉淀 12-48小时, 过滤, 将滤液回收乙醇并浓缩至相对密度约 1. 10- 1. 20, 加入等量的 (1) Extracting white scallion / red scallion: take the ratio of white scallion or scallion medicinal materials, add 6-10 times the amount of water to decoction and extract 2 to 4 times, each time 1-3 hours, after ^, combine the filtrate And concentrated the filtrate to a relative density of about 1.10-1.20, added 2-4 times the amount of an 80-95% ethanol solution, left the precipitate for 12-48 hours, filtered, recovered the filtrate and concentrated the ethanol to a relative density About 1. 10- 1. 20, add equal amounts
0. 1- 0· 3mol/L的 NaHC03溶液, 搅拌使溶解, 加入 3- 5倍量乙酸乙酯萃取 2-4 次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加入 2-5倍量 75-85%的 乙醇溶液使溶解,过滤,然后将滤液回 ^!t乙醇并浓缩至相对密度约 1. 10-1. 20, 喷雾干燥, 得白芍 /赤芍浸膏粉; 0. 1- 0 · 3mol / L NaHC0 3 solution, stir to dissolve, add 3-5 times the amount of ethyl acetate to extract 2-4 times, combine the ethyl acetate extracts, recover ethyl acetate to near dry, then add 2 -5 times the amount of 75-85% ethanol solution to dissolve, filter, and then filter the filtrate back to ^! T ethanol and concentrate to a relative density of about 1. 10-1. 20, spray-dried, to obtain white tincture / red tincture extract powder ;
( 2 )制备软胶嚢内容物: 取所述國 比的大豆油, 加热至 55-60°C , 加入 所述配比的大豆磷脂和蜂蜡, 使溶解 混匀后, 加入所述配比的薄荷素油, 混匀, 再边搅拌边加入(1 )步制得的白芍 /赤芍浸膏粉, 直至加完后继续搅 拌 20-60分钟, 再过胶体磨使充分混匀, 静置 8小时以上备用;  (2) Preparation of soft gelatine contents: Take the soybean oil of the national ratio, heat it to 55-60 ° C, add the soybean phospholipid and beeswax in the ratio, and after dissolving and mixing, add the ratio of the Peppermint oil, mix well, add the white scallion / red scallion extract powder prepared in step (1) while stirring, and continue stirring for 20-60 minutes after the addition is complete, and then mix thoroughly with colloid mill, let stand for 8 Spare for more than an hour;
( 3 )制备软胶片: 先配制 3-10%的氢氧化钠溶液备用; 另取适量纯化水, 加入所述配比的丙烯酸树脂 II和丙烯酸树脂 III,搅拌 20-60分钟,静置 40-120 分钟, 再边搅拌边加入预先配制好的氢氧化钠溶液, 碱化 40- 100分钟后转入 胶化锅内, 在搅拌条件下加热至 80- 85°C并保温 30- 60分钟,再加入所述配比 的明胶、 甘油和尼泊金乙酯, 继续加热并搅拌使明胶完全溶化, 在 80- 85 °C条 件下保温 30-60分钟, 抽真空除去部分水, 使其中的水分控制在 18- 35%左右, 再过 80目筛后转入稳胶桶中, 在 55- 60 °C条件下保温 10小时以上, 即制得胶 液; 然后将此胶液按常规工艺制成厚幕均匀且具有一定弹性的软胶片备用; (3) Preparation of soft film: first prepare a 3-10% sodium hydroxide solution for use; another appropriate amount of purified water is added, the acrylic resin II and acrylic resin III are added in the proportion, stirred for 20-60 minutes, and left to stand for 40- After 120 minutes, add the pre-prepared sodium hydroxide solution while stirring. After alkalizing for 40-100 minutes, transfer to a gelatinizer, heat to 80-85 ° C under stirring and keep for 30-60 minutes. Add the proportion of gelatin, glycerin and ethyl paraben, continue heating and stirring to completely dissolve the gelatin, keep it at 80-85 ° C for 30-60 minutes, and remove some water by vacuum to control the water content. At about 18-35%, go through a 80-mesh sieve and transfer it to a stable plastic barrel, and keep it at 55-60 ° C for more than 10 hours to obtain a glue solution; then make this glue solution according to the conventional process to make it thick. Soft film with uniform curtain and elasticity;
( 4 )制成软胶嚢: 将软胶嚢内容物和软胶片上软胶嚢压制机压制成一定 规格的软胶嚢, 即可。 其中, 上述(1) 步中提取制得的白芍 /赤芍浸膏粉中, 芍药苷的含量可 达到 30%(g/g)以上。 为了得到芍药苷含量更高的白芍 /赤芍浸膏粉, 还可通过 其它方法进一步精制。 (4) Making a soft gelatin capsule: The contents of the soft gelatin capsule and the soft gelatin capsule press on the soft film are pressed into a soft gelatin capsule of a certain specification. Wherein, the content of paeoniflorin in the Paeonia lactiflora / Red paeonia extract powder prepared in the above step (1) can reach more than 30% (g / g). In order to obtain the peony / red peony extract powder with higher paeoniflorin content, it can be further refined by other methods.
如有必要, 还可按照常规的包衣工艺, 在上述已制成的软胶嚢表面包上 一层肠溶型薄膜包衣, 以制成肠溶型软胶嚢。  If necessary, an enteric-type film coating can also be coated on the surface of the soft gelatin capsules prepared above according to a conventional coating process to form an enteric soft gelatin capsule.
本发明中所提到的薄荷素油, 为唇形科植物薄荷(Mentha haplocalyx Bi-iq.)的新鲜茎或叶经水蒸气蒸 留, 再冷冻, 部分脱脑加工得到的挥发油, 即中国药典 2000版一部所收载的薄荷油。 其质量应符合中国药典标准: 其中 含总醇量按薄荷脑(d。H2。0) 计算, 不得少于 50.0% (g/g)。 The menthol oil mentioned in the present invention is a volatile oil obtained from fresh stems or leaves of Labiatae mint (Mentha haplocalyx Bi-iq.) After being steam-steamed, frozen, and partially de-brained, namely Chinese Pharmacopoeia 2000 A contained mint oil. Its quality should comply with Chinese Pharmacopoeia standards: the total alcohol content is calculated according to menthol (d. H 2.0 ), and it should not be less than 50.0% (g / g).
薄荷素油可以从合法的原料药生产厂家购进, 也可以按照上述方法, 自 己从中药材薄荷中提取制得。  Peppermint oil can be purchased from legal API manufacturers, or it can be prepared from the Chinese herbal medicine peppermint according to the method described above.
本发明中所提到的白芍 /赤芍, 是指白芍、 赤芍或白芍和赤芍的混合物。 本发明所指的白芍, 为毛莨科植物芍药(Paeonia lactiflora Pall.)的 根经加工而成, 加工方法为: 釆 ½后除去头尾及须根, 刮去外皮, 置沸水中 煮至透心, 捞出放入冷水中浸泡, 取出干燥(或者先煮、 后刮外皮、 再干燥); 本发明中所提到的赤芍, 为毛莨科植物芍药(Paeonia lactiflora Pall.)或 川赤芍(Paeonia veitchii Lynch. )的干燥根。 中华人民共和国药典 2000年 版一部收载有白芍和赤芍, 二者的主要成分均为芍药苷, 其质量均应符合国 家标准, 其中: 白芍中含芍药苷(C i U不得少于 0.80% (g/g), 赤芍中含芍 药苷(C23H2S0u)不得少于 1.80% (g/g)。 In the present invention, the white peony / red peony refers to white peony, red peony, or a mixture of white peony and red peony. The Paeonia lactiflora referred to in the present invention is processed from the roots of Paeonia lactiflora Pall., And the processing method is as follows: after removing the head and tail and the fibrous roots, scrape off the skin, and cook in boiling water until thoroughly Remove the heart, soak it in cold water, and take it out for drying (or cook it first, then scrape the skin, and then dry it); The red scallion mentioned in the present invention is Paeonia lactiflora Pall. Or Sichuan red Dried root of Paeonia (Paeonia veitchii Lynch.). The 2000 edition of the Pharmacopoeia of the People's Republic of China contains paeonia lactiflora and paeonia lactiflora, both of which are mainly paeoniflorin, and their quality should meet the national standards. Among them: Paeonia lactiflora (C i U must not be less than 0.80% (g / g), paeoniflorin (C 23 H 2S 0 u ) in red peony must not be less than 1.80% (g / g).
与现有技术相比, 本发明的有益效果是: (1) .现有技术中没有一种与本 发明的中药组方相同的中药, 也没有针对性艮强的治疗肠易激综合症的中成 药, 本发明首次选用薄荷素油和白芍 /赤芍作为原料药的科学组方、 按一定的 重量配比组成, 经动物试猃和临床试验证明, 具有疏肝解郁、 镇痛抗炎、 调 气止泻等功效, 用于防治腹泻型肠易激综合征时针对性强, 疗效确切; 特别 是经过优选的配方具有特别优良的效果。 (2) .与化学药相比: 本发明药物中 薄荷素油和白芍 /赤芍均为常用的传统中药, 且经药理毒理试验证明, 其毒副 作用小, 安全性好, 而且成本低廉, 治疗费用较低。 ( 3) .与传统的汤剂、 丸 剂等相比, 本发明药物在制备过程中, 采用合理的提取工艺处理原料药中的 白芍 /赤芍药材, 能充分提取出其中的有效成分, 并减少杂质, 提高有效成分 的含量, 制成制剂后服用量较小, 每次仅需服用 2片或 2粒, 病人易于接受, 在一定程度上可提高病人的依从性。 此外, 制成适宜的制剂后其服用和携带 均较为方便。 薄荷素油中主要含薄荷醇 (Menthol, 40-60% )、 薄荷酮 (Menthone)等 成分: 具有驱风、 理气、 解郁、 消炎、 镇痛等功效, 有兴奋止呕、 抗抑郁等 作用。 白芍和赤芍的主要成分均为芍药苷(Paeoniflorin), 具有较好的扩张 血管、 镇痛镇静、 抗炎抗溃疡、 解热解痉、 利尿等作用, 且白芍和赤芍的副 作用较小, 具有良好的安全性和耐受性。 本发明药物将薄荷素油与白芍 /赤芍 合用, 科学搭配, 共奏疏肝解郁、 镇痛抗炎、 调气止泻之功。 Compared with the prior art, the beneficial effects of the present invention are: (1). In the prior art, there is no Chinese medicine that is the same as the traditional Chinese medicine prescription of the present invention, and there is no targeted treatment for irritable bowel syndrome. Chinese patent medicine, the invention uses for the first time a scientific formula of peppermint oil and paeonia lactiflora / red peony as a raw material medicine, and is composed of a certain weight ratio. It has been proven by animal tests and clinical trials to have liver relieving depression, analgesic and anti-inflammatory properties. The effects such as regulating qi and stopping diarrhea are used for prevention and treatment of diarrhea-type irritable bowel syndrome, and the effect is precise; especially the optimized formula has particularly excellent effect. (2) Compared with chemical medicines: The menthol oil and paeonia lactiflora and radix paeoniae in the medicine of the present invention are commonly used traditional Chinese medicines, and have been proven by pharmacological and toxicological tests to have small toxic and side effects, good safety, and low cost. The cost of treatment is low. (3) Compared with traditional decoctions, pills, etc., in the preparation process of the drug of the present invention, a reasonable extraction process is used to process the peony / red chrysanthemum material in the drug substance, and the effective ingredients can be fully extracted, and It can reduce impurities and increase the content of active ingredients. After taking the preparation, the dosage is small. It only needs to take 2 tablets or 2 capsules at a time. It is easy for patients to accept and can improve patient compliance to a certain extent. In addition, it is convenient to take and carry after making a suitable preparation. Menthol oil mainly contains menthol (Menthol, 40-60%), menthol (Menthone) and other ingredients: It has the effects of expelling wind, regulating qi, depressing, anti-inflammatory, analgesic, etc. It has the effects of excitement, anti-vomiting and anti-depression. The main components of Paeonia lactiflora and Paeonia lactiflora are Paeoniflorin, which have good effects of dilating blood vessels, analgesic and sedative, anti-inflammatory and anti-ulcer, antipyretic and spasm, and diuretic. Small, with good safety and tolerance. The medicament of the present invention combines peppermint oil with paeonia lactiflora and paeonia lactiflora in a scientific combination, and plays a role in relieving liver and stagnation, analgesic and anti-inflammatory, and regulating qi and diarrhea.
为证实本发明药物的疗效, 筛选出较优方案, 同时考察本发明药物的安 全性, 为临床用药提供理论依据, 发明人对其进行了动物药效学预试验、 动 物急性毒性试验和临床治疗试验等考察, 采用的方法和试验结果如下:  In order to confirm the efficacy of the drug of the present invention, a better plan was screened, and the safety of the drug of the present invention was also examined to provide a theoretical basis for clinical use. The inventors conducted animal pharmacodynamic pre-tests, animal acute toxicity tests and clinical treatments. The tests and other inspections adopted the following methods and test results:
一、 动物药效学预试验考察 (本发明药物对大鼠肠易激综合征腹泻模型 的影响)  I. Pre-examination of animal pharmacodynamics (Effect of the drug of the present invention on diarrhea model of irritable bowel syndrome in rats)
1.实验材料  Experimental material
1.1 药物  1.1 Drugs
不同原料药配比制成的本发明药物为自制, 以食用油稀释。 阳性对照药 易蒙停(盐酸洛派丁胺月交嚢) 为西安杨森制药有限公司产品。  The medicament of the present invention made with different drug substance ratios is homemade and diluted with edible oil. The positive control drug Yimengling (Luobutamide hydrochloride) was a product of Xi'an Yangsen Pharmaceutical Co., Ltd.
1.2 动物  1.2 Animals
SD大鼠 64只, 雄性, 体重 180±20g, 购自中国医学科学院实验动物研 究所。  Sixty-four SD rats, male, weighing 180 ± 20 g, were purchased from the Laboratory Animal Research Institute of the Chinese Academy of Medical Sciences.
2. 实验方法  Experimental method
2.1 动物分组情况  2.1 Grouping of animals
将大鼠随机分为 8组, 每组 8只, 即空白对照组 (灌胃给予食用油 Iml/lOOg), 阳性药组(易蒙停 2mg/kg)、 薄荷油和白芍 /赤芍按原料药组成配 比为 1:100(白芍)、 1:130(白芍)、 1:160(白芍)、 1: 130 (赤芍)设四个实验组 (第 1至 4组), 另设薄荷油组(笫 5组)和白芍组(笫 6组, 按本发明中提 取白芍 /赤芍的方法制备)。 按拟临床给药剂量的 10倍每天灌胃给药 1次, 连 续给药 6天。 每天给药后 1小时, 按照束縛应激大鼠肠易激综合征( IBS )腹 泻模型造模。 分组情况见表 1:  The rats were randomly divided into 8 groups of 8 rats each, namely the blank control group (injected with edible oil Iml / lOOg), the positive drug group (2 mg / kg Yimeng stop), peppermint oil, and peony / red The composition ratio of the drug substance is 1: 100 (white peony), 1: 130 (white peony), 1: 160 (white peony), 1: 130 (red peony). There are four experimental groups (groups 1 to 4). A peppermint oil group (笫 5 group) and a white) group (笫 6 group are prepared according to the method for extracting white 芍 / red 芍 in the present invention). 10 times of the intended clinical dose was administered orally once a day for 6 consecutive days. One hour after the daily administration, a diarrhea model of irritable bowel syndrome (IBS) in rats with restraint stress was made. See Table 1:
表 1 动物分组情况及给药剂量  Table 1 Grouping of animals and dosage
组别 薄荷油 ( g/kg ) 白芍 /赤芍 (生药, g/kg) 空白(食用油) 0 0  Group Peppermint oil (g / kg) Paeonia lactiflora / Red peony (raw medicine, g / kg) Blank (edible oil) 0 0
阳性药 (易蒙停) 0 0  Positive drug (easy to stop) 0 0
1 0.1 10 (白芍) 1 0.1 10 (white pheasant)
2 0.1 13 (白芍)2 0.1 13 (white pheasant)
3 0.1 16 (白芍) 4 0.1 13 (赤芍) 3 0.1 16 (white lotus) 4 0.1 13 (Chiba)
5 0.1 0  5 0.1 0
6 0 20 (白芍) 6 0 20 (white 芍)
2.2束縛应激大鼠肠易激综合征( IBS )腹泻模型 2.2 Model of irritable bowel syndrome (IBS) diarrhea in rats with restraint stress
每天取给药后的各组 SD大鼠, 分別灌胃给子蓖麻油 0. lml/100g后束縛 其两后肢, 使之行动不便, 烦躁不安, 造成一定的应激刺激。 如此连续 6天 造模后, 将大鼠分别放入垫有滤纸的代谢笼内, 每小时换吸水纸 1次, 记录 排便潜伏期、 腹泻率、 稀便率。  SD rats of each group were dosed daily after administration, and the castor oil was 0.1 g / 100 g, and both hind limbs were restrained, which made it difficult to move, irritable, and caused certain stress stimulation. After making the model in this way for 6 consecutive days, the rats were placed in metabolic cages with filter paper, and the absorbent paper was changed once an hour. The defecation latency, diarrhea rate, and loose stool rate were recorded.
3.实验结果  3. Experimental results
本发明药物各组均能明显延长蓖麻油致大鼠腹泻潜伏期, 明显减少累计 腹泻次数, 作用最低可维持至药后 2小时; 降低稀便率, 作用可维持至药后 6 小时。 与空白组比较差异显著(P<0.05), 结果见表 2、 表 3。  Each group of the medicine of the present invention can significantly prolong the incubation period of diarrhea caused by castor oil in rats, significantly reduce the cumulative number of diarrhea, and the effect can be maintained to a minimum of 2 hours after the medicine; the effect of reducing the loose stool rate can be maintained to 6 hours after the medicine. Compared with the blank group, the difference is significant (P <0.05). The results are shown in Tables 2 and 3.
表 2 对蓖麻油致大鼠腹泻模型的影响(1) ( =^; x土 s )  Table 2 Effects on castor oil-induced diarrhea in rats (1) (= ^; x 土 s)
腹泻潜伏期 累计腹泻次数  Diarrhea incubation period
组别  Group
(min) lh 2h 6h  (min) lh 2h 6h
空白 23.3±11.7 3.1±1.5 5.6±2.1 6.7±2.4 易蒙停 58.2±30.4* 1.4±1.2* 2.9±1.9^ ^ 4.3±2.1* Blank 23.3 ± 11.7 3.1 ± 1.5 5.6 ± 2.1 6.7 ± 2.4 Easy to stop 58.2 ± 30.4 * 1.4 ± 1.2 * 2.9 ± 1.9 ^ ^ 4.3 ± 2.1 *
1 45.9±29.1* 1.5±0.5* 3.4±2. ^ 4.6±2.7*1 45.9 ± 29.1 * 1.5 ± 0.5 * 3.4 ± 2. ^ 4.6 ± 2.7 *
2 53.9±24.1** 1.5±0.5* 3.4±2. In ^ 5.2±2.7*2 53.9 ± 24.1 ** 1.5 ± 0.5 * 3.4 ± 2. In ^ 5.2 ± 2.7 *
3 52.6±22.0** 1.6±1.5* 3.7±2.5^ ^ 5.0±3.1*3 52.6 ± 22.0 ** 1.6 ± 1.5 * 3.7 ± 2.5 ^ ^ 5.0 ± 3.1 *
4 52.1±23.2** 1.5±0.4* 3.6±2.2^ ^ 4.1±1.9*4 52.1 ± 23.2 ** 1.5 ± 0.4 * 3.6 ± 2.2 ^ ^ 4.1 ± 1.9 *
5 48.9±19.1* 1.7±0.5* 4.0±2.1^ ^ 6.0±3.75 48.9 ± 19.1 * 1.7 ± 0.5 * 4.0 ± 2.1 ^ ^ 6.0 ± 3.7
6 45.6±28.0* 1.6±1.5* 4.3±2.5 * 5.0±3·1* 6 45.6 ± 28.0 * 1.6 ± 1.5 * 4.3 ± 2.5 * 5.0 ± 3.1
注: *与空白组比较 P<0.05 **与空白组 匕较 P<0.01  Note: * Comparison with blank group P <0.05 ** Comparison with blank group P <0.01
表 3 对蓖麻油致大鼠腹泻模型的影响(2) ( n=8; x"± s )  Table 3 Effects on castor oil-induced diarrhea in rats (2) (n = 8; x "± s)
累计稀便率  Cumulative thin stool rate
組别  Group
lh 2h 6h  lh 2h 6h
空白 0.39±0.15 0.59±0.19 0.61±0.18  Blank 0.39 ± 0.15 0.59 ± 0.19 0.61 ± 0.18
易蒙停 0.18±0.14** 0.29±0.13** 0.39±0.14*  Yimeng stop 0.18 ± 0.14 ** 0.29 ± 0.13 ** 0.39 ± 0.14 *
1 0.33±0.18 0.38±0.30* 0.38±0.27* 1 0.33 ± 0.18 0.38 ± 0.30 * 0.38 ± 0.27 *
2 0.27±0.34* 0.40±0.40* 0.41±0.27*2 0.27 ± 0.34 * 0.40 ± 0.40 * 0.41 ± 0.27 *
3 0.18±0.23** 0.30±0.26** 0.36±0.25**3 0.18 ± 0.23 ** 0.30 ± 0.26 ** 0.36 ± 0.25 **
4 0.25±0.19* 0.32±0.21** 0.42±0.22*4 0.25 ± 0.19 * 0.32 ± 0.21 ** 0.42 ± 0.22 *
5 0.26±0.18* 0.46±0.30* 0.46±0· 27*5 0.26 ± 0.18 * 0.46 ± 0.30 * 0.46 ± 0 · 27 *
6 0.30±0.34 0.60±0.40 0.60±0.27 注: 与空白组比较 " ^ P<0.05 **与空白组比较 P<0.016 0.30 ± 0.34 0.60 ± 0.40 0.60 ± 0.27 Note: Compared with the blank group "^ P <0.05 ** Compared with the blank group P <0.01
4. 结论 4 Conclusion
本发明药物对蓖麻油所致大鼠肠易激综合征腹泻模型具有抑制作用 , 单用薄荷素油或单用白芍疗效更好, 与阳性对照药易蒙停疗效相当, 提示本 品具有很好的治疗肠易激综合征作用。 The medicine of the present invention has an inhibitory effect on diarrhea model of irritable bowel syndrome in rats caused by castor oil, The effect of peppermint oil alone or paeony is better, and it is equivalent to that of the positive control drug Yimeng stop, suggesting that this product has a good effect in treating irritable bowel syndrome.
二、 动物安全性试验考察  Second, animal safety test investigation
为了研究本发明药物的安全性, 为临床用药提供理论依据, 发明人对其 进行了急性毒性试验等考察, 试验结果如下:  In order to study the safety of the drug of the present invention and provide a theoretical basis for clinical use, the inventor conducted an investigation on the acute toxicity test and the like. The test results are as follows:
薄荷油的毒性很小, 灌胃时测不出 LD5。, 其最大耐受量大于 4000mg/kg , 此剂量为人体临床常用剂量的 670倍以上; 腹腔注射时 LD5。=1144. 9士 The toxicity of peppermint oil is very low, and LD 5 cannot be detected when given by gavage. The maximum tolerated amount is greater than 4000 mg / kg, which is more than 670 times the usual clinical dose in humans; LD 5 when intraperitoneally injected. = 1144. 9
78. 5mg/kg。 78. 5mg / kg.
白芍和赤芍均是中医传统常用药, 在千百年的实践中, 未曾发现它的毒 性和明显副作用。 现代医学急性毒理研究表明, 其口服安全性大。  Both white peony and red peony are traditionally used in traditional Chinese medicine, and their toxicity and obvious side effects have not been found in thousands of years of practice. Acute toxicology research in modern medicine shows that it is safe for oral administration.
经药理毒理试验研究的结果为:小鼠静脉注射与腹腔注射白芍提取物 (按 本发明药物制备方法中提取白芍 /赤芍的方法制得, 下同) 的 LD5。分别为 159mg/kg (相当于生药材约 12. 2g/kg )和 230mg/kg (相当于生药材约 The results of pharmacological and toxicological tests are: LD 5 of mice by intravenous injection and intraperitoneal injection of Paeonia lactiflora extract (prepared according to the method of extracting Paeonia lactiflora / Red paeony in the preparation method of the present invention, the same applies hereinafter). 159mg / kg (equivalent to approximately 12.2g / kg of raw medicinal materials) and 230mg / kg (equivalent to approximately of raw medicinal materials)
17. 7g/kg ); 喂饲小鼠白芍提取物约 3000 mg/kg (相当于生药材约 230g/kg ), 未见明显中毒症状, 也无死亡。 慢性毒理研究结果显示: 其对小鼠各重要脏 器无明显毒性。 大鼠和狗给予 3个不同剂量白芍提取物(每日胃饲 50 mg/kg、 1 000 mg/kg , 2000mg/kg , 相当于成人最高剂量的 5 - 200倍) 30天和 90天, 无明显毒性损害, 表明该药毒性低、 安全范围大。 三致试验均为阴性; 在帕 夫林生殖毒性试验(致畸胎儿试验)研究中, 给药剂量高达 2160mg/kg时, 仍无致畸作用, 对胎鼠存活、 外观及組织器官发育、 骨骼发育无明显影响。 此外, 白芍在中医中常用于安胎, 故提示白芍可能也适用于妊娠患者, 其安 全性较为可靠。 17. 7g / kg); Feeding mice with paeony extract about 3000 mg / kg (equivalent to about 230g / kg of raw medicinal materials), no obvious symptoms of poisoning and no death. The results of chronic toxicology studies showed that: it has no obvious toxicity to important organs of mice. Rats and dogs were given 3 different doses of Paeonia lactiflora extract (50 mg / kg, 1,000 mg / kg, 2000 mg / kg per day, equivalent to 5 to 200 times the highest adult dose) for 30 and 90 days. No obvious toxic damage, indicating that the drug has low toxicity and a large safety range. All three tests were negative; in the study of Paplin's reproductive toxicity test (teratogenic fetal test), when the dosage was as high as 2160mg / kg, there was still no teratogenic effect on the survival, appearance, tissue and organ development, bones of fetal rats. There was no significant effect on development. In addition, Amaranth is often used for abortion in Chinese medicine, so it is suggested that Amaranth may also be suitable for pregnant patients, and its safety is more reliable.
赤芍(按本发明药物制备方法中提取白芍 /赤芍的方法制得的提取物)小 鼠静脉注射的最大耐受量大于 50g/kg (生药材), 小鼠灌胃的最大耐受量大于 280 g/kg (生药材)。  Red peony (extract prepared according to the method for extracting white peony / red peony in the medicine preparation method of the present invention) The maximum tolerated amount for intravenous injection in mice is greater than 50g / kg (raw medicine), and the maximum tolerated for mice by intragastric administration The amount is greater than 280 g / kg (raw herbs).
口服灌胃本发明药物 (按原料药薄荷油:白芍配比为 1 : 130 ) 小鼠灌胃 LD5„=8670mg/kg , 此剂量为人体临床常用剂量的 300倍左右。 Oral gavage of the drug of the present invention (based on the drug substance peppermint oil: paeony ratio of 1: 130). Mice were gavage LD 5 "= 8670mg / kg, which is about 300 times the commonly used clinical dose in humans.
以上毒性试验结果提示: 本发明药物毒副作用较小, 安全性高。  The above toxicity test results suggest that the drug of the present invention has less toxic side effects and high safety.
三、 本发明药物治疗肠易激综合征的临床观察  Clinical observation of the drug of the present invention in treating irritable bowel syndrome
1、 临床资料  1. Clinical information
1. 1病例选择标准  1.1 Case selection criteria
1. 1. 1肠易激综合征(腹泻型)诊断标准  1. 1. 1 diagnostic criteria for irritable bowel syndrome (diarrhea type)
参照 1986年全国慢性腹泻学术讨论会临床诊断参考标准制订: ( 1)腹痛、 腹胀、 腹泻二年以上, 伴有全身性神经官能症^Formulated with reference to the clinical diagnostic reference standards of the National Symposium on Chronic Diarrhea in 1986: (1) Abdominal pain, bloating, diarrhea for more than two years, with systemic neurosis ^
(2) 一般情况良好, 无消瘦及发热, 系统体检仅发现腹部压痛。 (2) The general condition is good, no wasting and fever, and only a tenderness in the abdomen was found on the physical examination.
( 3) 多次粪常规及培养 (至少三次) 均阴性, 粪隐血实验阴性。  (3) Negative fecal routine and culture (at least three times) were negative, and fecal occult blood test was negative.
(4) X线钡剂灌肠检查无阳性发现, 或结肠有激惹现象。  (4) X-ray barium enema examination showed no positive findings or irritation of the colon.
(5)纤维结肠镜正常, 部分患者运动亢进, 粘液增多, 无明显粘膜异常, 组织学检查基本正常。  (5) Fiber colonoscopy is normal, some patients have hyperkinesia, increased mucus, no obvious mucosal abnormalities, and histological examination is basically normal.
(6 )血、 尿常规正常, 血沉正常  (6) blood and urine are normal and erythrocyte sedimentation is normal
(7)无痢疾、 血吸虫等寄生虫病史, 试验治疗无效。  (7) There is no history of parasites such as dysentery and schistosomiasis, and the test treatment is invalid.
1.1.2病例纳入标准  1.1.2 Case inclusion criteria
(1)符合肠易激综合征(腹泻型)诊断标准。  (1) Meet the diagnostic criteria for irritable bowel syndrome (diarrhea type).
(2)年龄 18—60岁的男性或女性。  (2) Male or female aged 18-60 years.
1.1.3病例排除标准  1.1.3 Case exclusion criteria
( 1 )肠道器质性疾病 (肿瘤、 炎症、 先天异常、 吸收不良综合征等)。  (1) Organic intestinal diseases (tumor, inflammation, congenital abnormalities, malabsorption syndrome, etc.).
(2)年龄在 18岁以下或 60岁以上, 妊娠或哺乳期妇女, 药物过敏史 或过敏体质者。  (2) Those under the age of 18 or over 60 years, pregnant or lactating women, a history of drug allergies or allergies.
( 3)合并心、 脑、 肝、 肾和造血系统等严重原发性疾病、 神病患者。  (3) Patients with severe primary diseases such as heart, brain, liver, kidney and hematopoietic system, and psychiatric diseases.
(4) 两周内接受过相关治疗, 可能影响疗效判定者。  (4) Those who have received relevant treatment within two weeks may affect the judgement of curative effect.
( 5 )不能按规定用药、 不符合纳入标准、 无法判定疗效或 t料不全等将 影响疗效或安全性判定者。  (5) Those who cannot use the drug according to the regulations, do not meet the inclusion criteria, cannot determine the curative effect, or have incomplete materials will affect the curative effect or safety determination.
(6)参加其它临床试验者。  (6) Participants in other clinical trials.
1、 2一般资料  1, 2 general information
全部病例均来自 2003年 1月至 2003年 11月门诊或住院病例。 按就诊顺 序随机分为治疗组及对照组, 治疗组 20例中男 11例、 女 9例; 斗龄最大 43 岁最小 25岁, 平均 35.51岁;病程最短' 2年, 最长 5年, 平均 3.27±1.36年。 对照组 20例中, 男 8例, 女 12例; 年龄最大 45岁、 最小 23岁, 平均 36.96 岁, 病程 2.2年~ 5.5年, 平均 3.85 ±1.03年。 两组患者的年龄、 性别、 病 史经统计学处理无明显差异, 具有可比性。  All cases were from outpatient or inpatient cases from January 2003 to November 2003. According to the order of consultation, they were randomly divided into treatment group and control group. Among the 20 patients in the treatment group, 11 were males and 9 were females. The maximum age was 43 years and the minimum age was 25 years, with an average of 35.51 years. 3.27 ± 1.36 years. Among the 20 cases in the control group, there were 8 males and 12 females; the oldest was 45 years old and the youngest was 23 years old, with an average of 36.96 years. The course of disease was 2.2 years to 5.5 years, with an average of 3.85 ± 1.03 years. There were no significant differences in the age, gender, and medical history of the two groups of patients, which were comparable.
2、 治疗方法  2. Treatment methods
采用双盲双模拟的方法, 治疗组给予本发明药物 (该药物的原料药组成 为: 薄荷素油 100g、 白芍 13000g、 大豆油 220g、 大豆磷脂 5g、 蜂蜡 5g, 制 成 1000粒软胶嚢), 口服, 1 日 3次, 2粒 /次; 对照组给予等剂量单味薄荷 素油所制的软胶嚢口服, 1 日 3次, 2粒 /次, 疗程均为 1个月。  Using the double-blind and double-simulation method, the treatment group was administered the drug of the present invention (the raw drug composition of the drug is: 100g of peppermint oil, 13000g of white peony, 220g of soybean oil, 5g of soybean phospholipid, 5g of beeswax, and 1000 soft capsules were made) Oral, 3 times a day, 2 capsules / time; the control group was given an equal dose of soft gelatin made of monomenthol oil, orally, 3 times a day, 2 capsules / time, the course of treatment was 1 month.
3、 疗效评定标准 采用症状分级评分标准(见表 4 )。 3. Efficacy Evaluation Standards Symptom grading criteria (see Table 4) were used.
症状分级评分标准表  Symptom grading scale
Figure imgf000011_0001
Figure imgf000011_0001
记录治疗前、 后症状总积分(各项症状分数相加), 采用积分比法进行疗 效评估。  The total score of symptoms before and after treatment (addition of each symptom score) was recorded, and the effect ratio was used to evaluate the effect.
积分比 = 治疗前积分-治疗后积分 X 100%  Points ratio = points before treatment-points after treatment X 100%
治疗前积分  Pre-treatment points
(1) 临床治愈: 症状消失, 观察和随访两周无复发。  (1) Clinical cure: The symptoms disappeared, and no recurrence was observed and followed for two weeks.
( 2 )显效: 临床症状明显改善, 症状积分比 > 70 %  (2) Significantly improved clinical symptoms, symptom score ratio> 70%
(3)有效: 临床症状有所好转, 症状积分比 > 30%, <70%0 (3) Effective: clinical symptoms improved, symptom score ratio> 30%, <70% 0
(4) 无效: 临床症状无明显改善, 甚或加重, 症状积分比 < 30%  (4) Ineffective: No obvious improvement in clinical symptoms, or even exacerbation, symptom score ratio <30%
4、 治疗结果 (见表 5)  4.Treatment results (see Table 5)
治疗后两组疗效比较  Comparison of the efficacy of the two groups after treatment
組别 - n 临床治愈( °/。 ) 显效 ( % ) 有效(% ) 无效(% ) 总有效率 (%) 治疗组 20 2 (10) 8 (40) 1 (5) 95 对照组 20 0 7 (35) 7 (35) 6 (30) 70 Group-n clinical cure (° /.) Markedly effective (%) effective (%) ineffective (%) total effective rate (%) treatment group 20 2 (10) 8 (40) 1 (5) 95 control group 20 0 7 (35) 7 (35) 6 (30) 70
注: 统计学处理两组总有效率对比 P<0.01,有显著性意义。 结论: 由以上结果可知, 本发明药物治疗肠易激综合征(腹泻型) 的总 有效率为 95%, 与单用薄荷素油的疗效相比有显著的统计学差异。 说明本发明 药物对肠易激综合征 (腹泻型)有明显的治疗作用。 具体实施方式 Note: The statistical comparison of the total effective rate between the two groups was P <0.01, which was significant. Conclusion: From the above results, the present invention is the pharmaceutical treatment of irritable bowel syndrome (diarrhea type) of the total effective rate was 95% efficacy alone and peppermint oil has a significant statistical difference compared. It shows that the medicine of the present invention has obvious therapeutic effect on irritable bowel syndrome (diarrhea type). detailed description
下面结合具体实施方式对本发明作进一步的详细描述。  The present invention is described in further detail below in conjunction with specific embodiments.
实施例一 本实施例为硬胶嚢剂,其胶嚢内容物的原料药组分为: 1份薄荷素油、 130 份白芍。 Example one This embodiment is a hard gum tincture, and the raw material components of the contents of the gum tincture are: 1 part of peppermint oil and 130 parts of white tincture.
按包括以下步骤的方法制成硬胶嚢剂:  Make a hard gel tincture by a method that includes the following steps:
(1 )提取白芍: 取所述配比的白芍药材, 加入 10倍量水煎煮提取 4 次, 每次 2小时, 过滤, 合并滤液, 并将滤液浓缩至相对密度约 1.10, 加入 2倍 量 80%的乙醇溶液, 静置沉淀 12小时, 过滤, 将滤液回收乙醇并浓缩至 目对 密度约 1.10, 加入等量的 0.2mol/L的 NaHC03溶液, 搅拌使溶解,加入 34咅量 乙酸乙酯萃取 2次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加入约 2 倍量 85%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并浓缩至相对密度为 1.10, 喷雾干燥, 得白芍浸膏粉; (1) Extracting Paeonia lactiflora: Take the medicinal materials of Paeonia lactiflora and add 10 times the amount of water to decoction and extract 4 times for 2 hours each time, filter, combine the filtrates, and concentrate the filtrates to a relative density of about 1.10, add 2 An 80% ethanol solution was doubled, and the precipitate was left standing for 12 hours, filtered, and the filtrate was recovered to ethanol and concentrated to a density of about 1.10. Add an equal amount of a 0.2mol / L NaHC0 3 solution, stir to dissolve, and add 34 , Extract twice with ethyl acetate, combine the ethyl acetate extracts, recover the ethyl acetate to near dryness, add about 2 times the 85% ethanol solution to dissolve, filter, and then recover the filtrate to ethanol and concentrate to a relative density of 1.10. Spray-dried to obtain white tincture extract powder;
(2)制成制剂: 取所述配比的薄荷素油, 与 (1 ) 步制得的白芍浸膏粉 混合均匀, 装入胶嚢壳, 制成 0.5g/粒的硬胶嚢, 即可。  (2) Formulation: Take the blended mint oil and mix it with the white tincture extract powder prepared in step (1), put it into the capsule shell, and make 0.5g / grain hard capsule, that is, can.
实施例二  Example two
本实施例为肠溶硬胶嚢剂,其胶嚢内容物的原料药组分为: 1份薄荷 油、 160份白芍、 0.01份硬脂酸镁。  This example is an enteric hard gelatin tincture. The raw material ingredients of the gelatin capsule are: 1 part of peppermint oil, 160 parts of white tincture, and 0.01 part of magnesium stearate.
按包括以下步骤的方法制成肠溶硬胶嚢剂:  An enteric hard gel tincture is prepared by a method that includes the following steps:
( 1 )提取白芍: 取所述配比的白芍药材, 加入 6倍量水煎煮提取 3欢, 每次 3小时, 过滤, 合并滤液, 并将滤液浓缩至相对密度约 1.20, 加入 4倍 量 95%的乙醇溶液, 静置沉淀 48小时, 过滤, 将滤液回收乙醇并浓缩至 目对 密度约 1.20, 加入等量的 0.2mol/L的 NaHC03溶液, 搅拌使溶解,加入 5倍量 乙酸乙酯萃取 4次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加人 2 倍量 85%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并浓缩至相对密度约 1.20, 喷雾干燥, 得白芍浸膏粉; (1) Extracting Paeonia lactiflora: Take the ratio of Paeonia lactiflora and add 6 times the amount of water to decoction to extract 3 Huan, each 3 hours, filter, combine the filtrate, and concentrate the filtrate to a relative density of about 1.20, add 4 Double the amount of 95% ethanol solution, leave it to stand for 48 hours, and filter. The filtrate is recovered and concentrated to a mesh density of about 1.20. An equal amount of 0.2mol / L NaHC0 3 solution is added. Stir to dissolve. Add 5 times the amount. Extracted 4 times with ethyl acetate, combined the ethyl acetate extracts, recovered ethyl acetate to near dryness, and added 2 times the amount of 85% ethanol solution to dissolve, filtered, and then recovered the filtrate to ethanol and concentrated to a relative density of about 1.20, Spray-dried to obtain white tincture extract powder;
(2)制成制剂: 取所述配比的薄荷素油和硬脂酸镁, 与 (1) 步制得的 白芍浸膏粉混合均匀, 装入肠溶胶嚢壳, 制成 0.5g/粒的硬胶嚢, 即可。  (2) Preparation: take the mentioned ratio of menthin oil and magnesium stearate, mix it with the white tincture extract powder prepared in step (1), and put it into the intestine tin shell to make 0.5g / grain Of hard gelatin, just fine.
实施例三  Example three
本实施例为肠溶硬胶嚢剂,其胶嚢内容物的原料药组分为: 1份薄荷 t油、 80份赤芍。  This embodiment is an enteric hard gelatin tincture. The raw material ingredients of the gelatin capsule are: 1 part of mint t oil and 80 parts of red tincture.
按包括以下步骤的方法制成肠溶硬胶嚢剂:  An enteric hard gel tincture is prepared by a method that includes the following steps:
(1 )提取赤芍: 取所述配比的赤芍药材, 加入 8倍量水煎煮提取 2 :次, 每次 1小时, 过滤, 合并滤液, 并将滤液浓缩至相对密度约 1.15, 加入 3倍 量 85%的乙醇溶液, 静置沉淀 16小时, 过滤, 将滤液回收乙醇并浓缩至 目对 密度约 1.15, 加入等量的 0.2mol/L的 NaHC03溶液, 搅拌使溶解,加入 4倍量 乙酸乙酯萃取 3次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加入 5 倍量 75%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并浓缩至相对密度约 1.10, 喷雾干燥, 得赤芍浸膏粉; (1) Extracting red scallion: Take the red scallion medicinal materials with the proportion and add 8 times the amount of water to cook and extract 2: twice for 1 hour each time, filter, combine the filtrates, and concentrate the filtrates to a relative density of about 1.15, add 3 times the amount of 85% ethanol solution, left standing for 16 hours, filtered, the filtrate was recovered ethanol and concentrated to a mesh density of about 1.15, the same amount of 0.2mol / L NaHC0 3 solution was added, stirred to dissolve, added 4 times the amount Extract 3 times with ethyl acetate, combine the ethyl acetate extracts, recover the ethyl acetate to near dryness, add 5 times the amount of 75% ethanol solution to dissolve, filter, then recover the filtrate to ethanol and concentrate to a relative density of about 1.10, spray Dried to obtain red chrysalis extract powder;
(2)制成制剂: 取所述配比的薄荷素油, 与 (1) 步制得的赤芍浸膏粉 混合均匀, 装入肠溶胶嚢壳, 制成 0.5g/粒的硬胶嚢, 即可。  (2) Formulation: take the mentioned ratio of menthol oil, mix it with the red chrysanthemum extract powder prepared in step (1), and put it into the intestine husk to make 0.5 g / capsule of hard gelatine. Just fine.
实施例四  Example 4
本实施例为薄膜包衣片剂, 其片芯的原料药组分为: 1份薄荷素油、 180 份白芍、 5份玉米淀粉。  This embodiment is a film-coated tablet, and the raw material components of the core are: 1 part of peppermint oil, 180 parts of white peony, and 5 parts of corn starch.
按包括以下步骤的方法制成片剂:  Tablets are made by a method that includes the following steps:
( 1 )提取白芍: 取所述配比的白芍药材, 加入 7倍量水煎煮提取 3次, 第一次 3小时, 第二、 三次每次 1.5小时, 过滤, 合并滤液, 并将滤液浓缩 至相对密度约 1.15, 加入 3倍量 90%的乙醇溶液, 静置沉淀 18小时, 过滤, 将滤液回收乙醇并浓缩至相对密度约 1.15, 加入等量的 0.2mol/L的 NaHC03 溶液, 搅拌使溶解, 加入 4倍量乙酸乙酯萃取 3次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加入 4倍量 80%的乙醇溶液使溶解, 过滤, 然后 ^夺滤 液回收乙醇并浓缩至相对密度约 1.15, 喷雾干燥, 得白芍浸膏粉; (1) Extracting Paeonia lactiflora: Take the medicinal materials of Paeonia lactiflora and add 7 times the amount of water to decoction and extract 3 times, 3 hours for the first time, 1.5 hours for the second and third times, filter, combine the filtrates, and The filtrate was concentrated to a relative density of about 1.15, 3 times the amount of a 90% ethanol solution was added, and the precipitate was left to stand for 18 hours, filtered, the filtrate was recovered to ethanol and concentrated to a relative density of about 1.15, and an equal amount of a 0.2mol / L NaHC0 3 solution was added. , Stir to dissolve, add 4 times the amount of ethyl acetate and extract 3 times, combine the ethyl acetate extracts, recover the ethyl acetate to near dry, then add 4 times the amount of 80% ethanol solution to dissolve, filter, and then recover the filtrate Ethanol and concentrated to a relative density of about 1.15, spray-dried to obtain white tincture extract powder;
(2)制成制剂: 取所述配比的薄荷素油和玉米淀粉, 与 (1 ) 步制得的 白芍浸膏粉混合均匀, 按常规工艺压制成 0.5g/片的片芯,再在片芯表面包上 一层薄膜包衣, 即可。  (2) Preparation: Take the mentioned ratio of peppermint oil and corn starch, mix with the Paeonia lactiflora powder obtained in step (1), uniformly press into a 0.5g / tablet core according to the conventional process, and then The surface of the tablet core is covered with a film coating.
实施例五  Example 5
本实施例为肠溶型薄膜包衣的片剂, 其片芯的原料药组分为: 1份薄荷素 油、 100份赤芍。  This embodiment is an enteric film-coated tablet. The raw material components of the tablet core are: 1 part of peppermint oil and 100 parts of red pepper.
按包括以下步骤的方法制成片剂:  Tablets are made by a method that includes the following steps:
( 1 )提取赤芍: 取所述配比的赤芍药材, 加入 9倍量水煎煮提取 2次, 每次 1.5小时, 过滤, 合并滤液, 并将滤液浓缩至相对密度约 1.18, 加入 4 倍量 90%的乙醇溶液, 静置沉淀 24小时, 过滤, 将滤液回收乙醇并浓缩至相 对密度约 1.15, 加入等量的 0.2mol/L的 NaHC03溶液, 搅拌使溶解, 加入 5 倍量乙酸乙酯萃取 2次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加 入 3倍量 80%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并浓缩至相对密 度约 1.15, 喷雾干燥, 得赤芍浸膏粉; (1) Extracting red scallion: Take the red scallion medicinal materials with the proportion, add 9 times the amount of water to cook and extract twice, 1.5 hours each time, filter, combine the filtrates, and concentrate the filtrates to a relative density of about 1.18, add 4 90% ethanol solution, settle for 24 hours, and filter. The filtrate was recovered and concentrated to a relative density of about 1.15. An equal amount of 0.2mol / L NaHC0 3 solution was added, stirred to dissolve, and 5 times the amount of acetic acid was added. Extract twice with ethyl acetate, combine the ethyl acetate extracts, recover the ethyl acetate to near dryness, add 3 times the amount of 80% ethanol solution to dissolve, filter, and then recover the filtrate to ethanol and concentrate to a relative density of about 1.15, spray-dried To get red chrysanthemum extract powder;
(2 )制成制剂: 取所述配比的薄荷素油, 与 (1) 步制得的赤芍浸膏粉 混合均匀,按常规工艺压制成 0.5g/片的片芯,再在片芯表面包上一层肠溶型 薄膜包衣, 即可。 实施例六 (2) Formulation: Take the mentioned ratio of menthol oil, mix with the red chrysanthemum extract powder obtained in step (1), uniformly press into a tablet core of 0.5 g / tablet according to the conventional process, and then place it on the surface of the tablet core. Cover with an enteric film coating. Embodiment 6
本实施例为软胶嚢剂, 其中:  This embodiment is a soft gel tincture, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 150份白芍、 2. 6份茶油。 软胶片由以下重量配比的组分组成: 3份明胶、 1份甘油、 0. 009份尼泊 金曱酯、 1. 6份水。  The drug substance components of the contents of the soft gum tincture are: 1 part of peppermint oil, 150 parts of white tincture, and 2.6 parts of tea oil. The soft film is composed of the following weight ratio components: 3 parts of gelatin, 1 part of glycerin, 0.09 part of paraben, 1.6 parts of water.
按包括以下步骤的方法制成软胶嚢剂:  Make a soft gel tincture by a method that includes the following steps:
( 1 )提取白芍: 取所述配比的白芍药材, 加入 8倍量水煎煮提取 3次, 每次 2. 5小时, 过滤, 合并滤液, 并将滤液浓缩至相对密度约 1. 10, 加入 2 倍量 95°/。的乙醇溶液, 静置沉淀 30小时, 过滤, 将滤液回收乙醇并浓缩至相 对密度约 1. 18, 加入等量的 0. 2mol/L的 NaHC03溶液, 搅拌使溶解, 加入 3 倍量乙酸乙酯萃取 4次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加 入 3倍量 80%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并浓缩至相对密 度为 1. 15 , 喷雾干燥, 得白芍浸膏粉; (1) Extraction of Paeonia lactiflora: Take the medicinal materials of Paeonia lactiflora and add 8 times the amount of water to decoction and extract 3 times, 2.5 hours each time, filter, combine the filtrates, and concentrate the filtrates to a relative density of about 1. 10, add 2 times the amount of 95 ° /. The ethanol solution was left standing for 30 hours, filtered, and the filtrate was recovered and concentrated to a relative density of about 1.18. An equal amount of a 0.2mol / L NaHC0 3 solution was added, stirred to dissolve, and 3 times the amount of ethyl acetate was added. Ester extraction 4 times, combined ethyl acetate extracts, recovered ethyl acetate to near dryness, then added 3 times the amount of 80% ethanol solution to dissolve, filtered, and then recovered the filtrate to ethanol and concentrated to a relative density of 1.15, spray Dried to obtain white tincture extract powder;
( 2 )制备软胶嚢内容物: 取所述配比的茶油, 加热至 58 °C左右, 加入所 述配比的薄荷素油, 混匀, 再边搅拌边加入(1 )步制得的白芍浸膏粉, 直至 加完后继续搅拌 1小时, 使混合均匀, 再过胶体磨使进一步混匀, 静置 10小 时以上备用;  (2) Preparation of soft gelatin content: Take the proportion of tea oil, heat to about 58 ° C, add the proportion of menthol oil, mix well, and add the prepared in step (1) while stirring. Paeonia lactiflora powder, continue to stir for 1 hour until the addition is complete, so that the mixture is uniform, and then colloid mill to make further mixing, let it stand for more than 10 hours;
( 3 )制备软胶片: 取适量純化水, 加入所述配比的明胶、 甘油和尼泊金 曱酯, 加热并搅拌使明胶完全溶化, 在 85 Ό条件下保温 30分钟, 抽真空除去 部分水,使其中的水分控制在 29%左右,再过 80目筛后转入稳胶桶中,在 55-60 °C条件下保温 12小时以上, 即制得胶液; 然后将此胶液按常规工艺制成厚薄 均匀且具有一定弹性的软胶片备用;  (3) Preparation of soft film: Take an appropriate amount of purified water, add the ratio of gelatin, glycerin and nipaginate, heat and stir to completely dissolve the gelatin, keep it at 30 ° C for 30 minutes, and remove some water by vacuum Control the moisture in it to about 29%. After passing through 80 mesh sieve, transfer it to a stable plastic barrel, and keep it at 55-60 ° C for more than 12 hours to obtain a glue solution. Then, use this glue solution as usual. Process to make soft film with uniform thickness and certain elasticity for future use;
( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0. I 粒的软胶嚢, 即可。  (4) Making soft gelatin capsules: press the soft gelatin capsules into the contents of the soft gelatin capsules and press the soft gelatin capsules into 0.1 soft gelatin capsules.
实施例七  Example Seven
本实施例为软胶嚢剂, 其中:  This embodiment is a soft gel tincture, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 140份白芍、 2. 4份大豆 油、 0. 07份大豆磷脂、 0. 03份蜂蜡。  The drug substance components of the contents of the soft capsules are: 1 part of peppermint oil, 140 parts of peony, 2.4 parts of soybean oil, 0.07 parts of soybean phospholipids, and 0.03 parts of beeswax.
软胶片由以下重量配比的组分组成: 3份明胶、 1. 5份甘油、 1份水。 按包括以下步骤的方法制成软胶嚢剂:  The soft film is composed of the following weight ratio components: 3 parts gelatin, 1.5 parts glycerin, 1 part water. Make a soft gel tincture by a method that includes the following steps:
( 1 )提取白芍: 取所述配比的白芍药材, 加入 10倍量水煎煮提取 4次, 每次 2小时, 过滤, 合并滤液, 并将滤液浓缩至相对密度约 1. 20, 加入 3倍 量 85%的乙醇溶液, 静置沉淀 36小时, 过滤, 将滤液回收乙醇并浓缩至相对 密度约 1.12, 加入等量的 0.2mol/L的 NaHC03溶液, 搅拌使溶解, 加入 5倍量 乙酸乙酯萃取 2次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加入 2 倍量 85%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并浓缩至相对密度约 1.18, 喷雾干燥, 得白芍浸膏粉; (1) Extracting white peony: take the ratio of white peony, add 10 times the amount of water to cook and extract 4 times, 2 hours each time, filter, combine the filtrate, and concentrate the filtrate to a relative density of about 1. 20, 3 times the amount of 85% ethanol solution was added, and the precipitate was allowed to stand for 36 hours, filtered, and the filtrate was recovered into ethanol and concentrated to a relative amount. Density is about 1.12, add an equal amount of 0.2mol / L NaHC0 3 solution, stir to dissolve, add 5 times the amount of ethyl acetate to extract twice, combine the ethyl acetate extracts, recover the ethyl acetate to near dry, and then add 2 times The amount of 85% ethanol solution was dissolved, filtered, and then the filtrate was recovered ethanol and concentrated to a relative density of about 1.18, and spray-dried to obtain Baiji extract powder;
(2)制备软胶嚢内容物: 取所述配比的大豆油, 加热至 60°C左右, 加入 所述配比的大豆磷脂和蜂蜡, 使溶解并混匀后, 加入所述配比的薄荷素油, 混匀, 再边搅拌边加入(1) 步制得的白芍浸膏粉, 直至加完后继续搅拌 20 分钟, 使混合均句, 再过胶体磨使进一步混勾, 静置 8小时以上备用;  (2) Preparation of soft gelatin content: Take the soybean oil with the ratio, heat it to about 60 ° C, add the soybean phospholipid and beeswax in the ratio, and after dissolving and mixing, add the ratio Menthol oil, mix well, add the white peony extract powder obtained in step (1) while stirring, and continue stirring for 20 minutes after the addition is complete, and then mix evenly with colloid mill. Let stand 8 Spare for more than an hour;
(3)制备软胶片: 取适量纯化水, 加入所述配比的明胶和甘油, 加热并 搅拌使明胶完全溶化, 在 85°C条件下保温 30分钟, 抽真空除去部分水, 使其 中的水分控制在 18%左右, 再过 80目筛后转入稳胶桶中, 在 55- 60°C条件下 保温 12小时以上, 即制得胶液; 然后将此胶液按常规工艺制成厚薄均匀且具 有一定弹性的软胶片备用;  (3) Preparation of soft film: Take an appropriate amount of purified water, add the gelatin and glycerin in the proportion, heat and stir to completely dissolve the gelatin, keep it at 30 ° C for 30 minutes, and remove some water by vacuum to make the water in it. Controlled at about 18%, after passing through 80 mesh sieve, it was transferred to a stable plastic bucket, and kept at 55-60 ° C for more than 12 hours to obtain a glue solution. Then the glue solution was made into a uniform thickness according to a conventional process. And a flexible film with a certain elasticity is reserved;
( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0.5g/ 粒的软胶嚢, 即可。  (4) Making soft gelatin capsules: The contents of the soft gelatin capsules and the soft gelatin capsule press on the soft film are pressed into a soft gelatin capsule of 0.5 g / grain, and then the process is completed.
实施例八  Example eight
本实施例为软胶嚢剂, 其中:  This embodiment is a soft gel tincture, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 130份白芍、 2.2份大豆 油、 0.05份大豆磷脂、 0.05份蜂蜡。  The drug substance components of the contents of the soft capsules are: 1 part of peppermint oil, 130 parts of peony, 2.2 parts of soybean oil, 0.05 parts of soybean phospholipids, and 0.05 parts of beeswax.
软胶片由以下重量配比的组分组成: 3份明胶、 1.5份甘油、 0.8份丙烯 酸树脂 II、 0.4份丙烯酸树脂 III、 0.01份尼泊金乙酯、 0.21份氢氧化钠、 2.5 份水。  The soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.5 parts of glycerin, 0.8 parts of acrylic resin II, 0.4 parts of acrylic resin III, 0.01 parts of paraben ethyl ester, 0.21 parts of sodium hydroxide, 2.5 parts of water.
按包括以下步骤的方法制成软胶嚢剂:  Make a soft gel tincture by a method that includes the following steps:
(1)提取白芍: 取所述配比的白芍药材, 加入 8倍量水煎煮提取 2次, 第一次 2小时, 第二次 1小时, 过滤, 合并滤液, 并将滤液浓缩至相对密度 约 1, 15, 加入 3倍量 85%的乙醇溶液, 静置沉淀 16小时, 过滤, 将滤液回收 乙醇并浓缩至相对密度约 1.15,加入等量的 0.2mol/L的 NaHC03溶液,搅拌使 溶解, 加入 4倍量乙酸乙酯萃取 3次, 合并乙酸乙酯萃取液, 回收乙酸乙酯 至近干, 再加入 3倍量 80%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并 浓缩至相对密度约 1.15, 喷雾干燥, 得白芍浸膏粉; (1) Extracting Paeonia lactiflora: Take the medicinal materials of Paeonia lactiflora and add 8 times the amount of water to decoction and extract it twice, the first time is 2 hours, and the second time is 1 hour. Filter, combine the filtrates, and concentrate the filtrates to The relative density is about 1, 15, 3 times the amount of 85% ethanol solution is added, the precipitate is left for 16 hours, filtered, the filtrate is recovered ethanol and concentrated to a relative density of about 1.15, and an equal amount of a 0.2mol / L NaHC0 3 solution is added. Stir to dissolve, add 4 times the amount of ethyl acetate and extract 3 times, combine the ethyl acetate extracts, recover the ethyl acetate to near dry, add 3 times the amount of 80% ethanol solution to dissolve, filter, and then recover the filtrate by ethanol. Concentrated to a relative density of about 1.15, spray-dried to obtain Baiji extract powder;
(2)制备软胶嚢内容物: 取所述配比的大豆油, 加热至 55°C左右, 加入 所述配比的大豆磷脂和蜂蜡, 使溶解并混勾后, 加入所述配比的薄荷素油, 混匀, 再边搅拌边加入(1) 步制得的白芍浸膏粉, 直至加完后继续搅拌 30 分钟, 使混合均匀, 再过胶体磨使进一步混匀, 静置 12小时以上备用;(2) Preparation of soft gelatin content: Take the proportion of soybean oil, heat it to about 55 ° C, add the proportion of soybean phospholipid and beeswax, dissolve and mix, and add the proportion of Peppermint oil, mix well, add the white peony extract powder obtained in step (1) while stirring, and continue stirring until the addition is complete. Minutes, make the mixture uniform, and then colloid mill to further mix, let stand for more than 12 hours;
( 3 )制备软胶片: 先配制约 6. 5% ( g/g ) 的氢氧化钠溶液备用; 另取适 量纯化水, 加入所述配比的丙烯酸树脂 II和丙烯酸树脂 III , 搅拌 30分钟, 静 置 1小时, 再边搅拌边加入预先配制好的氢氧化钠溶液, 碱化 1小时后转入 胶化锅内, 在搅拌条件下加热至约 80Ό并保温 45分钟,再加入所述配比的明 胶、 甘油和尼泊金乙酯, 继续加热并搅拌使明胶完全溶化, 在 80 °C条件下保 温 30分钟, 抽真空除去部分水, 使其中的水分控制在 30%左右, 再过 80目筛 后转入稳胶桶中, 在 55- 60Ό条件下保温 12小时以上, 即制得胶液; 然后将 此胶液按常规工艺制成厚薄均勾且具有一定弹性的软胶片备用; (3) Preparation of soft film: first prepare about 6.5% (g / g) sodium hydroxide solution for use; another appropriate amount of purified water is added, the acrylic resin II and acrylic resin III are added in the proportion, and stirred for 30 minutes, Allow to stand for 1 hour, and then add the pre-prepared sodium hydroxide solution while stirring. After alkalizing for 1 hour, transfer to a gelatinizer, heat to about 80Ό under stirring and keep for 45 minutes, then add the proportion Gelatin, glycerin, and ethyl paraben, continue to heat and stir to completely dissolve the gelatin, keep it at 80 ° C for 30 minutes, and remove some of the water by vacuum to control the moisture in it to about 30%. After sieving, it is transferred to a stable plastic barrel, which is kept under the condition of 55-60 ° C for more than 12 hours to obtain a glue solution. Then the glue solution is made into a thick and thin flexible film with a certain elasticity according to conventional processes for use;
( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0. 5g/ 粒的软胶嚢, 即可。  (4) Making soft gelatin capsules: The contents of the soft gelatin capsules and the soft gelatin capsules on the soft film are pressed into a soft gelatin capsule of 0.5 g / capsule.
实施例九  Example Nine
本实施例为软胶嚢剂, 其中:  This embodiment is a soft gel tincture, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 100份赤芍、 2. 4份大豆 油、 0. 07份大豆磷脂、 0. 03份蜂蜡。  The drug substance components of the contents of the soft capsule are: 1 part of peppermint oil, 100 parts of red pepper, 2.4 parts of soybean oil, 0.07 parts of soybean phospholipid, and 0.03 parts of beeswax.
软胶片由以下重量配比的组分组成: 3份明胶、 1. 8份甘油、 0. 9份丙烯 酸树脂 II、 0. 5份丙烯酸树脂 III、 0. 009份尼泊金乙酯、 0. 20份氢氧化钠、 2. 6 份水。  The soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.8 parts of glycerin, 0.9 parts of acrylic resin II, 0.5 parts of acrylic resin III, 0.09 parts of paraben ethyl ester, 0. 20 parts sodium hydroxide, 2.6 parts water.
按包括以下步骤的方法制成软胶嚢剂:  Make a soft gel tincture by a method that includes the following steps:
( 1 )提取赤芍: 取所述配比的赤芍药材, 加入 6倍量水煎煮提取 4次, 每次 1. 5小时, 过滤, 合并滤液, 并将滤液浓缩至相对密度约 1. 12 , 加入 4 倍量 80%的乙醇溶液, 静置沉淀 12小时, 过滤, 将滤液回收乙醇并浓缩至相 对密度约 1. 10 , 加入等量的 0. 2mol /L的 NaHC03溶液, 搅拌使溶解, 加入 5 倍量乙酸乙酯萃取 2次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加 入 4倍量 75%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并浓缩至相对密 度约 1. 20 , 喷雾干燥, 得赤芍浸膏粉; (1) Extracting red scallion: take the ratio of red scallion medicinal materials, add 6 times the amount of water to cook and extract 4 times, 1.5 hours each time, filter, combine the filtrates, and concentrate the filtrate to a relative density of about 1. 12, add 4 times the amount of 80% ethanol solution, leave the precipitate for 12 hours, filter, recover the filtrate and concentrate the ethanol to a relative density of about 1. 10, add an equal amount of 0.2mol / L NaHC0 3 solution, stir to make was dissolved, was added 5 volumes of ethyl acetate and extracted twice with ethyl acetate extracts were combined, ethyl acetate recovered to near dryness, then added 4-fold amount of 75% ethanol solution to dissolve, filtered, then the filtrate was concentrated and recovering ethanol To a relative density of about 1.20, spray-dried to obtain red chrysanthemum extract powder;
( 2 )制备软胶嚢内容物: 取所述配比的大豆油, 加热至 60°C左右, 加入 所述配比的大豆磷脂和蜂蜡, 使溶解并混匀后, 加入所述配比的薄荷素油, 混匀, 再边搅拌边加入(1 ) 步制得的赤芍浸膏 4分, 直至加完后继续搅拌 20 分钟, 使混合均匀, 再过胶体磨使进一步混匀, 静置 8小时以上备用;  (2) Preparation of the contents of soft gelatine: Take the soybean oil with the ratio, heat it to about 60 ° C, add the soybean phospholipid and beeswax in the ratio, and after dissolving and mixing, add the ratio Menthol oil, mix well, add the red chrysanthemum extract prepared in step (1) for 4 minutes while stirring, and continue stirring for 20 minutes until the addition is complete, and then mix evenly with colloid mill. Let stand 8 Spare for more than an hour;
( 3 )制备软胶片: 先配制约 10% ( g/g )的氢氧化钠溶液备用; 另取适量 纯化水, 加入所述配比的丙烯酸树脂 II和丙烯酸树脂 III, 搅拌 20分钟, 静置 2小时, 再边搅拌边加入预先配制好的氢氧化钠溶液,碱化 100分钟后转入胶 化锅内,在搅拌条件下加热至约 82 Ό并保温 30分钟,再加入所述配比的明胶、 甘油和尼泊金乙酯, 继续加热并搅拌使明胶完全溶化, 在 82 °C条件下保温 45 分钟, 抽真空除去部分水, 使其中的水分控制在 29%左右, 再过 80目筛后转 入稳胶桶中, 在 55- 60°C条件下保温 10小时以上, 即制得胶液; 然后将此胶 液按常规工艺制成厚薄均匀且具有一定弹性的软胶片备用; (3) Preparation of soft film: first prepare about 10% (g / g) sodium hydroxide solution for use; another appropriate amount of purified water is added, the acrylic resin II and acrylic resin III are added in the proportion, stirred for 20 minutes, and left to stand 2 hours, add the pre-prepared sodium hydroxide solution while stirring, turn to gel after 100 minutes of alkalization In a chemical pot, heat to about 82 ° C with stirring for 30 minutes, add the gelatin, glycerin, and paraben ethyl ester in the ratio, continue to heat and stir to completely dissolve the gelatin, at 82 ° C Incubate for 45 minutes, vacuum remove part of the water, control the moisture content to about 29%, and then transfer it to a stable plastic bucket after passing through an 80 mesh sieve. Keep it at 55-60 ° C for more than 10 hours to obtain the glue. This glue is then made into a soft film with a uniform thickness and a certain elasticity according to the conventional process for later use;
( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0. 5g/ 粒的软胶嚢, 即可。  (4) Making soft gelatin capsules: The contents of the soft gelatin capsules and the soft gelatin capsules on the soft film are pressed into a soft gelatin capsule of 0.5 g / capsule.
实施例十 ·  Example 10
本实施例为软胶嚢剂, 其中:  This embodiment is a soft gel tincture, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 160份白芍、 3份大豆油、 0. 02份大豆磷脂、 0. 02份蜂蜡。  The drug substance components of the contents of the soft capsule are: 1 part of peppermint oil, 160 parts of peony, 3 parts of soybean oil, 0.02 parts of soybean phospholipid, and 0.02 parts of beeswax.
软胶片由以下重量配比的组分组成: 3份明胶、 2. 4份甘油、 0. 6份丙烯 酸树脂 II、 0. 3份丙烯酸树脂 III、 0. 008份尼泊金丙酯、 0. 24份氢氧化钠、 2. 4 份水。  The soft film is composed of the following weight ratio components: 3 parts of gelatin, 2.4 parts of glycerin, 0.6 parts of acrylic resin II, 0.3 parts of acrylic resin III, 0.008 parts of paraben propyl, 0. 24 parts of sodium hydroxide, 2.4 parts of water.
按包括以下步骤的方法制成软胶嚢剂:  Make a soft gel tincture by a method that includes the following steps:
( 1 )提取白芍: 取所述配比的白芍药材, 加入 10倍量水煎煮提取 3次, 每次 2小时, 过滤, 合并滤液, 并将滤液浓缩至相对密度约 1. 18 , 加入 3倍 量 90%的乙醇溶液, 静置沉淀 24小时, 过滤, 将滤液回收乙醇并浓缩至相对 密度约 1. 18 ,加入等量的 0. 2mol /L的 NaHC03溶液,搅拌使溶解, 加入 3倍量 乙酸乙酯萃取 4次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加入 4 倍量 75%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并浓缩至相对密度为 1. 20 , 喷雾干燥, 得白芍浸膏粉; (1) Extraction of Paeonia lactiflora: take the medicinal materials of Paeonia lactiflora, add 10 times the amount of water to decoction and extract 3 times, each time for 2 hours, filter, combine the filtrates, and concentrate the filtrates to a relative density of about 1.18, Add 3 times the amount of 90% ethanol solution, leave the precipitate for 24 hours, filter, recover the filtrate and concentrate the ethanol to a relative density of about 1.18, add an equal amount of 0.2mol / L NaHC0 3 solution, stir to dissolve, Add 3 times the amount of ethyl acetate for extraction 4 times, combine the ethyl acetate extracts, recover the ethyl acetate to near dry, then add 4 times the amount of 75% ethanol solution to dissolve, filter, then recover the filtrate to ethanol and concentrate to relative density For 1. 20, spray-dried to obtain white tincture extract powder;
( 2 )制备软胶嚢内容物: 取所述配比的大豆油, 加热至 56 Ό左右, 加入 所述配比的大豆磷脂和蜂蜡, 使溶解并混勾后, 加入所述配比的薄荷素油, 混匀, 再边搅拌边加入(1 ) 步制得的白芍浸膏粉, 直至加完后继续搅拌 60 分钟, 使混合均匀, 再过胶体磨使进一步混匀, 静置 12小时以上备用;  (2) Preparation of soft gelatine contents: Take the proportion of soybean oil, heat it to about 56 Ό, add the proportion of soybean phospholipids and beeswax, dissolve and mix, and add the proportion of mint The vegetable oil is mixed well, and the white peony extract powder prepared in step (1) is added while stirring. Continue stirring for 60 minutes until the addition is complete, and then mix evenly with colloid mill. Let stand for more than 12 hours. Spare
( 3 )制备软胶片: 先配制约 3% ( g/g ) 的氢氧化钠溶液备用; 另取适量 纯化水, 加入所述配比的丙烯酸树脂 II和丙烯酸树脂 III , 搅拌 60分钟, 静置 1. 5小时, 再边搅拌边加入预先配制好的氢氧化钠溶液, 减化 40分钟后转入 胶化锅内, 在搅拌条件下加热至约 83 °C并保温 1小时, 再加入所述配比的明 胶、 甘油和尼泊金丙酯, 继续加热并搅拌使明胶完全溶化, 在 83 °C条件下保 温 1小时, 抽真空除去部分水, 使其中的水分控制在 27%左右, 再过 80目筛 后转入稳胶桶中, 在 55- 60°C条件下保温 10小时以上, 即制得月交液; 然后将 此胶液按常规工艺制成厚薄均匀且具有一定弹性的软胶片备用;(3) Preparation of soft film: first prepare about 3% (g / g) sodium hydroxide solution for use; another appropriate amount of purified water is added, the acrylic resin II and acrylic resin III are added in the proportion, stirred for 60 minutes, and left to stand 1. 5 hours, add the pre-prepared sodium hydroxide solution while stirring, reduce to 40 minutes, transfer to a gelatinizer, heat to about 83 ° C and keep it for 1 hour under stirring, then add the Proportion of gelatin, glycerin and propyl paraben. Continue heating and stirring to completely dissolve the gelatin, keep it at 83 ° C for 1 hour, and remove some of the water by vacuum to control the moisture in it to about 27%. After 80 mesh sieve, it is transferred to a stable plastic barrel, and it is kept at 55-60 ° C for more than 10 hours, and then the monthly liquid is obtained; This glue solution is made into a soft film with uniform thickness and certain elasticity according to the conventional process.
( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0. 5g/ 粒的软胶嚢, 即可。 (4) Making soft gelatin capsules: The contents of the soft gelatin capsules and the soft gelatin capsules on the soft film are pressed into a soft gelatin capsule of 0.5 g / capsule.
实施例十一  Example 11
本实施例为软胶嚢剂, 其中:  This embodiment is a soft gel tincture, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 120份白芍、 2份大豆油、 0. 03份大豆磷脂、 0. 08份蜂蜡。  The drug substance components of the contents of the soft capsule are: 1 part of peppermint oil, 120 parts of peony, 2 parts of soybean oil, 0.03 parts of soybean phospholipid, and 0.08 parts of beeswax.
软胶片由以下重量配比的组分组成: 3份明胶、 0. 8份甘油、 0. 7份丙烯 酸树脂 II、 0. 6份丙烯酸树脂 III、 0. 011份尼泊金乙酯、 0. 18份氢氧化钠、 1 份水。  The soft film is composed of the following weight ratio components: 3 parts of gelatin, 0.8 parts of glycerin, 0.7 parts of acrylic resin II, 0.6 parts of acrylic resin III, 0.011 parts of paraben ethyl ester, 0. 18 parts of sodium hydroxide, 1 part of water.
按包括以下步骤的方法制成软胶嚢剂:  Make a soft gel tincture by a method that includes the following steps:
( 1 )提取白芍: 取所述配比的白芍药材, 加入 7倍量水煎煮提取 4次, 每次 1小时, 过滤, 合并滤液, 并将滤液浓缩至相对密度约 1. 16 , 加入 2倍 量 95%的乙醇溶液, 静置沉淀 18小时, 过滤, 将滤液回收乙醇并浓缩至相对 密度约 1. 16 , 加入等量的 0. 2mol /L的 NaHC03溶液, 搅拌使溶解, 加入 4倍量 乙酸乙酯萃取 3次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加入 3 倍量 80°/。的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并浓缩至相对密度约 1. 16 , 喷雾干燥, 得白芍浸膏粉; (1) Extraction of Paeonia lactiflora: Take the medicinal materials of Paeonia lactiflora, add 7 times the amount of water to decoction and extract 4 times, each time for 1 hour, filter, combine the filtrates, and concentrate the filtrates to a relative density of about 1.16, Add 2 times the amount of 95% ethanol solution, leave it to stand for 18 hours, filter, recover the filtrate and concentrate it to a relative density of about 1.16, add an equal amount of 0.2mol / L NaHC0 3 solution, stir to dissolve, Add 4 times the amount of ethyl acetate and extract 3 times, combine the ethyl acetate extracts, recover the ethyl acetate to near dry, and then add 3 times the amount of 80 ° /. The ethanol solution was dissolved, filtered, and then the filtrate was recovered ethanol and concentrated to a relative density of about 1.16, and spray-dried to obtain a white tincture extract powder;
( 2 )制备软胶嚢内容物: 取所述配比的大豆油, 加热至 58 °C左右, 加入 所述配比的大豆磷脂和蜂蜡, 使溶解并混匀后, 加入所述配比的薄荷素油, 混匀, 再边搅拌边加入(1 ) 步制得的白芍浸膏粉, 直至加完后继续搅拌 50 分钟, 使混合均匀, 再过胶体磨使进一步混匀, 静置 1 0小时以上备用; (2) Preparation of the contents of soft gelatine: Take the soybean oil with the ratio, heat it to about 58 ° C, add the soybean phospholipid and beeswax in the ratio, and after dissolving and mixing, add the ratio Menthol oil, mix well, add the white peony extract powder obtained in step (1) while stirring, and continue stirring for 50 minutes after the addition is complete, and then mix evenly with colloid mill. Let stand for 1 0 Spare for more than an hour;
( 3 )制备软胶片: 先配制约 5% ( g / g ) 的氢氧化钠溶液备用; 另取适量 纯化水, 加入所述配比的丙烯酸树脂 II和丙烯酸树脂 III , 搅拌 50分钟, 静置 40分钟, 再边搅拌边加入预先配制好的氢氧化钠溶液,碱化 50分钟后转入胶 化锅内, 在搅拌条件下加热至约 85 °C并保温 1小时,再加入所述配比的明胶、 甘油和尼泊金乙酯, 继续加热并搅拌使明胶完全溶化, 在 85 °C条件下保温 1 小时, 抽真空除去部分水, 使其中的水分控制在 27%左右, 再过 80目筛后转 入稳胶桶中, 在 55-60 °C条件下保温 12小时以上, 即制得胶液; 然后将此胶 液按常规工艺制成厚薄均匀且具有一定弹性的软胶片备用; (3) Preparation of soft film: first prepare about 5% (g / g) sodium hydroxide solution for use; another appropriate amount of purified water is added, the acrylic resin II and acrylic resin III are added in the proportion, stirred for 50 minutes, and left to stand For 40 minutes, add the pre-prepared sodium hydroxide solution while stirring. After alkalizing for 50 minutes, transfer to a gelatinizer, heat to about 85 ° C and keep it for 1 hour under stirring. Then add the ratio Gelatin, glycerin, and ethyl paraben, continue to heat and stir to completely dissolve the gelatin, keep it at 85 ° C for 1 hour, and remove some water by vacuuming to keep the moisture in it at about 27%. After sieving, it is transferred to a stable plastic barrel, and it is kept at 55-60 ° C for more than 12 hours to obtain a glue solution. Then, the glue solution is made into a soft film with uniform thickness and a certain elasticity according to a conventional process for use;
( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0. 5g/ 粒的软胶嚢, 即可。  (4) Making soft gelatin capsules: The contents of the soft gelatin capsules and the soft gelatin capsules on the soft film are pressed into a soft gelatin capsule of 0.5 g / capsule.
实施例十二 本实施例为肠溶软胶嚢剂, 其中: Embodiment 12 This embodiment is an enteric soft gel liniment, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 180份白芍、 1. 5份大豆 油、 0. 08份大豆磷脂、 0. 07份蜂蜡。  The drug substance components of the contents of the soft gum tincture are: 1 part of peppermint oil, 180 parts of peony, 1.5 parts of soybean oil, 0.08 parts of soybean phospholipids, and 0.007 parts of beeswax.
软胶片由以下重量配比的组分组成: 3份明胶、 1. 2份甘油、 1份丙烯酸 树脂 II、 0. 2份丙烯酸树脂 III、 0. 012份尼泊金乙酯、 0. 18份氢氧化钠、 3份 水。  The soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.2 parts of glycerin, 1 part of acrylic resin II, 0.2 parts of acrylic resin III, 0.012 parts of paraben ethyl ester, 0.18 parts Sodium hydroxide, 3 parts of water.
在制剂表面还包有一层肠溶型薄膜包衣。  The surface of the preparation is also coated with an enteric film coating.
按包括以下步骤的方法制成肠溶软胶嚢剂:  An enteric soft gel tincture is prepared by a method that includes the following steps:
( 1 )提取白芍: 取所述配比的白芍药材, 加入 8倍量水煎煮提取 3次, 每次 2. 5小时, 过滤, 合并滤液, 并将滤液浓缩至相对密度约 1. 14 , 加入 3 倍量 90%的乙醇溶液, 静置沉淀 20小时, 过滤, 将滤液回收乙醇并浓缩至相 对密度约 1. 14 , 加入等量的 0. 3mol/L的 NaHC03溶液, 搅拌使溶解, 加入 3 倍量乙酸乙酯萃取 4次, 合并乙酸乙酯萃取液, 回收乙酸乙酯至近干, 再加 入 4倍量 75%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙醇并浓缩至相对密 度约 1. 14 , 喷雾干燥, 得白芍浸膏粉; (1) Extraction of Paeonia lactiflora: Take the medicinal materials of Paeonia lactiflora and add 8 times the amount of water to decoction and extract 3 times, 2.5 hours each time, filter, combine the filtrates, and concentrate the filtrates to a relative density of about 1. 14, add 3 times the amount of 90% ethanol solution, leave the precipitate for 20 hours, filter, recover the filtrate and concentrate the ethanol to a relative density of about 1.14, add an equal amount of 0.3 mol / L NaHC0 3 solution, stir to make Dissolve, add 3 times the amount of ethyl acetate and extract 4 times, combine the ethyl acetate extracts, recover the ethyl acetate to near dry, then add 4 times the amount of 75% ethanol solution to dissolve, filter, and then recover the filtrate to ethanol and concentrate to The relative density is about 1.14, and spray-dried to obtain white tincture extract powder;
( 2 )制备软胶嚢内容物: 取所述配比的大豆油, 加热至 57 °C左右, 加入 所述配比的大豆磷脂和蜂蜡, 使溶解并混匀后, 加入所述配比的薄荷素油, 混匀, 再边搅拌边加入(1 ) 步制得的白芍浸膏粉, 直至加完后继续搅拌 40 分钟, 使混合均匀, 再过胶体磨使进一步混匀, 静置 12小时以上备用;  (2) Preparation of the contents of soft gelatine: take the soybean oil with the ratio, heat it to about 57 ° C, add the soybean phospholipid and beeswax in the ratio, and after dissolving and mixing, add the ratio Menthol oil, mix well, add the white peony extract powder obtained in step (1) while stirring, and continue to stir for 40 minutes until the addition is complete, and then mix evenly with colloid mill. Let stand for 12 hours Above spare
( 3 )制备软胶片: 先配制约 8% ( g/g ) 的氢氧化钠溶液备用; 另取适量 纯化水, 加入所述配比的丙烯酸树脂 II和丙烯酸树脂 III , 搅拌 40分钟, 静置 100分钟, 再边搅拌边加入预先配制好的氢氧化钠溶液, 碱化 80分钟后转入 胶化锅内, 在搅拌条件下加热至约 84°C并保温 40分钟,再加入所述配比的明 胶、 甘油和尼泊金乙酯, 继续加热并搅拌使明胶完全溶化, 在 84°C条件下保 温 40分钟, 抽真空除去部分水, 使其中的水分控制在 35%左右, 再过 80目筛 后转入稳胶桶中, 在 55- 60Ό条件下保温 12小时以上, 即制得胶液; 然后将 此胶液按常规工艺制成厚薄均匀且具有一定弹性的软胶片备用;  (3) Preparation of soft film: first prepare an approximately 8% (g / g) sodium hydroxide solution for use; another appropriate amount of purified water is added, the acrylic resin II and acrylic resin III are added in the proportion, stirred for 40 minutes, and left to stand For 100 minutes, add the pre-prepared sodium hydroxide solution while stirring. After alkalizing for 80 minutes, transfer to a gelatinizer, heat to about 84 ° C and keep it for 40 minutes under stirring. Then add the ratio Gelatin, glycerin, and ethyl paraben, continue to heat and stir to completely dissolve the gelatin, keep it at 84 ° C for 40 minutes, and remove some water by vacuuming to control the water content to about 35%. After sieving, it is transferred to a stable plastic barrel, which is kept under the condition of 55-60 ° C for more than 12 hours to obtain a glue solution. Then, the glue solution is made into a thin film with a uniform thickness and a certain elasticity according to a conventional process for use;
( 4 )制成肠溶软胶嚢: 将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0. 5g/粒的软胶嚢, 再按常规的包衣工艺在其表面包上一层肠溶型薄膜包衣, 即可。  (4) Made of enteric soft gelatin: The soft gelatin content and the soft gelatin on a soft film are compressed into a soft gelatin gel by a press of 0.5 g / granule, and then coated on the surface according to a conventional coating process. An enteric film coating is sufficient.
实施例十三  Example 13
本实施例为肠溶软胶嚢剂, 其中:  This embodiment is an enteric soft gel liniment, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 80份赤芍、 2. 2份花生油、 0. 05份大豆磷脂、 Q. 05份蜂蜡。 The drug substance components of the contents of the soft capsule are: 1 part of peppermint oil, 80 parts of red pepper, 2.2 parts of peanut oil, 0. 05 parts of soybean phospholipid, Q. 05 parts of beeswax.
软胶片由以下重量配比的组分组成: 3份明胶、 1. 5份甘油、 0. 8份丙烯 酸树脂 II、 0. 4份丙烯酸树脂 III、 0. 01份尼泊金乙酯、 0. 21份氢氧化钠、 2. 5 份水。  The soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.5 parts of glycerin, 0.8 parts of acrylic resin II, 0.4 parts of acrylic resin III, 0.01 parts of paraben ethyl ester, 0. 21 parts sodium hydroxide, 2.5 parts water.
在制剂表面还包有一层肠溶型薄膜包衣。  The surface of the preparation is also coated with an enteric film coating.
按包括以下步骤的方法制成肠溶软胶嚢剂:  An enteric soft gel tincture is prepared by a method that includes the following steps:
( 1 )提取赤芍: 取所述配比的赤芍药材, 加入 9倍量水煎煮提取 2次, 第一次 2. 5小时, 第二次 1. 5小时, 过滤, 合并滤液, 并将滤液浓缩至相对 密度约 1. 17 , 加入 4倍量 80%的乙醇溶液, 静置沉淀 32小时, 过滤, 将滤液 回收乙醇并浓缩至相对密度约 1. 17 ,加入等量的 0. lmol/L的 NaHC03溶液,搅 拌使溶解, 加入 5倍量乙酸乙酯萃取 2次, 合并乙酸乙酯萃取液, 回收乙酸 乙酯至近干, 再加入 2倍量 85%的乙醇溶液使溶解, 过滤, 然后将滤液回收乙 醇并浓缩至相对密度约 1. 17 , 喷雾干燥, 得赤芍浸膏粉; (1) Extracting red scallion: take the ratio of red scallion medicinal materials, add 9 times the amount of water to cook and extract twice, the first 2.5 hours, the second 1.5 hours, filter, combine the filtrates, and Lmol The filtrate was concentrated to a relative density of about 1.17, 4 times the amount of 80% ethanol solution was added, the precipitate was left for 32 hours, filtered, the filtrate was recovered ethanol and concentrated to a relative density of about 1.17, and an equal amount of 0.1 lmol was added. / L NaHC0 3 solution, stir to dissolve, add 5 times the amount of ethyl acetate and extract twice, combine the ethyl acetate extracts, recover the ethyl acetate to dryness, then add 2 times the 85% ethanol solution to dissolve, and filter Then, the filtrate was recovered to ethanol and concentrated to a relative density of about 1.17, and spray-dried to obtain red scallion extract powder;
( 2 )制备软胶嚢内容物: 取所述配比的花生油, 加热至 58 °C左右, 加入 所述配比的大豆磷脂和蜂蜡, 使溶解并混匀后, 加入所述配比的薄荷素油, 混匀, 再边搅拌边加入(1 ) 步制得的赤芍浸膏粉, 直至加完后继续搅拌 30 分钟, 使混合均匀, 再过胶体磨使进一步混匀, 静置 12小时以上备用;  (2) Preparation of soft gelatine contents: Take the proportion of peanut oil, heat it to about 58 ° C, add the proportion of soybean phospholipid and beeswax, dissolve and mix, and add the proportion of mint Mix the vegetable oil, and then add the red chrysanthemum extract powder obtained in step (1) while stirring. Continue to stir for 30 minutes until the addition is complete, and then mix evenly with colloid mill. Let stand for more than 12 hours. Spare
( 3 )制备软胶片: 先配制约 6. 5% ( g/g ) 的氢氧化钠溶液备用; 另取适 量纯化水, 加入所述配比的丙烯酸树脂 II和丙烯酸树脂 III , 搅拌 30分钟, 静 置 60分钟, 再边搅拌边加入预先配制好的氢氧化钠溶液, 碱化 60分钟后转 入胶化锅内, 在搅拌条件下加热至约 82 °C并保温 45分钟, 再加入所述配比的 明胶、 甘油和尼泊金乙酯, 继续加热并搅拌使明胶完全溶化, 在 82 °C条件下 保温 40分钟, 抽真空除去部分水, 使其中的水分控制在 30%左右, 再过 80目 筛后转入稳胶桶中, 在 55- 60°C条件下保温 12小时以上, 即制得胶液; 然后 将此胶液按常规工艺制成厚薄均勾且具有一定弹性的软胶片备用;  (3) Preparation of soft film: first prepare about 6.5% (g / g) sodium hydroxide solution for use; another appropriate amount of purified water is added, the acrylic resin II and acrylic resin III are added in the proportion, and stirred for 30 minutes, Allow to stand for 60 minutes, and then add the pre-prepared sodium hydroxide solution while stirring. After alkalizing for 60 minutes, transfer to a gelatinizer, heat to about 82 ° C and keep it for 45 minutes under stirring. Proportion of gelatin, glycerin, and ethyl paraben. Continue heating and stirring to completely dissolve the gelatin. Incubate at 82 ° C for 40 minutes. Vacuum to remove part of the water, and control the water content to about 30%. After 80 mesh sieve, it is transferred to a stable plastic barrel, and it is kept at 55-60 ° C for more than 12 hours to obtain a glue solution. Then, the glue solution is made into a soft film with a uniform thickness and a certain elasticity according to a conventional process. Spare
( 4 )制成肠溶软胶嚢: 将软胶嚢内容物和软胶片上软胶囊压制机压制成 0. 5g/粒的软胶嚢, 再按常规的包衣工艺在其表面包上一层肠溶型薄膜包衣, 即可。  (4) Made of enteric soft gelatin capsules: The contents of the soft gelatin capsules and the soft capsules on a soft capsule press are pressed into a soft gel capsule of 0.5g / granule, and then the surface is coated with a conventional coating process for one An enteric film coating is sufficient.
实施例十四  Embodiment 14
本实施例为软胶嚢剂, 其中: 软胶嚢内容物的原料药组分为: 1份薄荷素 油、 100份白芍、 2. 5份大豆植物油、 0. 1份大豆磷脂、 0. 1份蜂蜡。  This embodiment is a soft gum tincture, wherein: the raw material medicine components of the soft gum tincture are: 1 part of peppermint oil, 100 parts of peony, 2.5 parts of soybean vegetable oil, 0.1 part of soybean phospholipid, 0.1 Portions of beeswax.
软胶片由以下重量配比的组分组成: 3份明胶、 1. 5份甘油、 1份水。 制备方法: (1)、 按照实施例八步骤(1) 中提取方法提取白芍, 得白芍浸膏粉;The soft film is composed of the following weight ratio components: 3 parts gelatin, 1.5 parts glycerin, 1 part water. Preparation: (1) Extract the Paeonia lactiflora according to the extraction method in step (1) of Example 8 to obtain Paeonia lactiflora extract powder;
(2)、 取所述配比的大豆植物油, 加热至 55°C左右, 加入所述配比的大 豆磷脂和蜂蜡, 使溶解并混勾后, 加入所述配比的薄荷素油, 混匀 , 再边搅 拌边加入(1) 步制得的白芍浸膏粉, 直至加完后继续搅拌 30分钟左右, 使 混合均匀, 静置 12小时以上备用; (2) taking the ratio of soybean vegetable oil, heating it to about 55 ° C, adding the ratio of soybean phospholipid and beeswax, dissolving and mixing the mixture, adding the ratio of mint oil, and mixing, Add the Paeonia lactiflora powder obtained in step (1) while stirring, and continue to stir for about 30 minutes after the addition is complete, so that the mixture is homogeneous, and let stand for more than 12 hours for use;
(3)、 制备软胶片: 取适量纯化水, 加入所述配比的明胶和甘油, 加热 并搅拌使明胶完全溶化, 混勾后在 85°C条件下保温 30分钟,抽真空除去部分 水, 使其中的水分含量为 25%, 再过 80目筛后转入稳胶桶中, 在 55-60°C条 件下保温 12小时以上, 即制得胶液; 然后将此胶液按常规工艺制成厚薄均匀 且具有一定弹性的软胶片备用;  (3) Preparation of soft film: Take an appropriate amount of purified water, add the gelatin and glycerin in the proportions, heat and stir to completely dissolve the gelatin, and keep it at 85 ° C for 30 minutes after mixing the hooks, and remove some water by vacuum. Make the moisture content of 25%, and then transfer it to the glue stabilization barrel after passing through a 80 mesh sieve. Keep the glue at 55-60 ° C for more than 12 hours to obtain a glue solution. Then make this glue solution according to the conventional process. Prepare soft film with uniform thickness and elasticity;
( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0.5g/ 粒的软胶嚢, 即可。  (4) Making soft gelatin capsules: The contents of the soft gelatin capsules and the soft gelatin capsule press on the soft film are pressed into a soft gelatin capsule of 0.5 g / grain, and then the process is completed.
实施例十五  Example 15
本实施例为软胶嚢剂, 其中:  This embodiment is a soft gel tincture, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 80份白芍、 2.0份大豆植 物油、 0.1份蜂蜡。  The drug substance components of the contents of soft capsules are: 1 part of peppermint oil, 80 parts of peony, 2.0 parts of soybean vegetable oil, and 0.1 part of beeswax.
软胶片由以下重量配比的组分组成: 3份明胶、 1.6份甘油、 0.9份水。 制备方法:  The soft film is composed of the following weight ratio components: 3 parts gelatin, 1.6 parts glycerin, 0.9 parts water. Preparation:
(1)、 按照实施例八步骤(1) 中提取方法提取白芍, 得白芍浸膏粉; (1) Extract the Paeonia lactiflora according to the extraction method in step (1) of Example 8 to obtain Paeonia lactiflora extract powder;
(2)、 取所述配比的大豆植物油, 加热至 55°C左右, 加入所述配比蜂蜡, 使溶解并混匀后, 加入所述配比的薄荷素油, 混匀, 再边搅拌边加入(1)步 制得的白芍浸膏粉, 直至加完后继续搅拌 30分钟左右, 使混合均匀, 静置 12 小时以上备用; (2) Take the proportion of soybean vegetable oil, heat it to about 55 ° C, add the proportion of beeswax, dissolve and mix, add the proportion of menthol oil, mix well, and stir while stirring Add the Paeonia lactiflora powder obtained in step (1), and continue to stir for about 30 minutes after the addition is complete, so that the mixture is homogeneous, and let stand for more than 12 hours for use;
(3)、 制备软胶片: 取适量纯化水, 加入所述配比的明胶和甘油, 加热 并搅拌使明胶完全溶化, 混勾后在 85°C条件下保温 30分钟,抽真空除去部分 水, 使其中的水分含量为 20%, 再过 80目筛后转入稳胶桶中, 在 55-60°C条 件下保温 12小时以上, 即制得胶液; 然后将此胶液按常规工艺制成厚薄均匀 且具有一定弹性的软胶片备用;  (3) Preparation of soft film: Take an appropriate amount of purified water, add the gelatin and glycerin in the proportions, heat and stir to completely dissolve the gelatin, and keep it at 85 ° C for 30 minutes after mixing the hooks, and remove some water by vacuum. Make the moisture content of 20%, and then transfer it to a glue stabilization barrel after passing through a 80 mesh sieve. Keep the glue at 55-60 ° C for more than 12 hours to obtain a glue solution. Then make this glue solution according to the conventional process. Prepare soft film with uniform thickness and elasticity;
( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0.5g/ 粒的软胶嚢, 即可。  (4) Making soft gelatin capsules: The contents of the soft gelatin capsules and the soft gelatin capsule press on the soft film are pressed into a soft gelatin capsule of 0.5 g / grain, and then the process is completed.
实施例十六  Embodiment 16
本实施例为软胶嚢剂, 其中:  This embodiment is a soft gel tincture, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 130份赤芍、 3份大豆植 物油。 The drug substance components of the contents of soft capsules are: 1 part of peppermint oil, 130 parts of red pepper, 3 parts of soybean plant Oil.
软胶片由以下重量配比的组分组成: 3份明胶、 1.2份甘油、 0.5份水。 制备方法:  The soft film consists of the following weight ratio components: 3 parts gelatin, 1.2 parts glycerin, 0.5 parts water. Preparation:
( 1 )、 按照实施例八步驟(1 ) 中提取方法提取赤芍, 得赤芍浸膏粉; (1) Extracting red peony according to the extraction method in step (1) of Example 8 to obtain red peony extract powder;
(2)、 取所述配比的大豆植物油, 加热至 55°C左右, 加入所述配比的薄 荷素油, 混匀, 再边搅拌边加入(1) 步制得的赤芍浸膏粉, 直至加完后继续 搅拌 30分钟左右, 使混合均匀, 静置 12小时以上备用; (2) Take the proportion of soybean vegetable oil, heat it to about 55 ° C, add the proportion of menthol oil, mix well, and then add the red scallion extract powder obtained in step (1) while stirring, Continue to stir for about 30 minutes after the addition is complete, make the mixture uniform, and let it stand for more than 12 hours;
( 3)、 制备软胶片: 取适量纯化水, 加入所述配比的明胶和甘油, 加热 并搅拌使明胶完全溶化, 混匀后在 85°C条件下保温 30分钟,抽真空除去部分 水, 使其中的水分含量为 18%, 再过 80目筛后转入稳胶桶中, 在 55-60Ό条 件下保温 12小时以上, 即制得胶液; 然后将此胶液按常规工艺制成厚薄均匀 且具有一定弹性的软胶片备用;  (3) Preparation of soft film: Take an appropriate amount of purified water, add the proportion of gelatin and glycerin, heat and stir to completely dissolve the gelatin, mix and keep at 85 ° C for 30 minutes, and remove some water by vacuum. Make the moisture content of 18%, and then transfer it to a stable plastic bucket after passing through a 80 mesh sieve. Keep the glue for more than 12 hours at 55-60 ° C to obtain a glue solution. Then make this glue solution according to the conventional process. Soft film with uniform and certain elasticity;
( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0.5g/ 粒的软胶嚢, 即可。  (4) Making soft gelatin capsules: The contents of the soft gelatin capsules and the soft gelatin capsule press on the soft film are pressed into a soft gelatin capsule of 0.5 g / grain, and then the process is completed.
实施例十七  Example 17
本实施例为软胶嚢剂, 其中:  This embodiment is a soft gel tincture, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 160份赤芍、 2.8份大豆 植物油。  The drug substance components of the contents of soft capsules are: 1 part of peppermint oil, 160 parts of red pepper, 2.8 parts of soybean vegetable oil.
软胶片由以下重量配比的组分组成: 3份明胶、 1.2份甘油、 0.5份水、 0.01份尼泊金乙酯。  The soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.2 parts of glycerin, 0.5 parts of water, 0.01 parts of paraben ethyl ester.
制备方法:  Preparation:
( 1 )、 按照实施例八步骤(1 ) 中提取方法提取赤芍, 得赤芍浸膏粉; (1) Extracting red peony according to the extraction method in step (1) of Example 8 to obtain red peony extract powder;
(2)、 取所述配比的大豆植物油, 加热至 55°C左右, 加入所述配比的薄 荷素油, 混匀, 再边搅拌边加入( 1 )步制得的赤芍浸膏粉, 直至加完后继续 搅拌 30分钟左右, 使混合均匀, 静置 12小时以上备用; (2) taking the proportion of soybean vegetable oil, heating it to about 55 ° C, adding the proportion of menthol oil, mixing well, and then adding the red chrysanthemum extract powder obtained in step (1) while stirring, Continue to stir for about 30 minutes after the addition is complete, make the mixture uniform, and let it stand for more than 12 hours;
( 3)、 制备软胶片: 取适量纯化水, 加入所述配比的明胶和甘油, 加热 并搅拌使明胶完全溶化, 再加入所述配比的尼泊金乙酯, 混匀后在 85°C条件 下保温 30分钟, 抽真空除去部分水, 使其中的水分含量为 33%, 再过 80目筛 后转入稳胶桶中, 在 55- 60°C条件下保温 12小时以上, 即制得胶液; 然后将 此胶液按常规工艺制成厚薄均匀且具有一定弹性的软胶片备用;  (3) Preparation of soft film: Take an appropriate amount of purified water, add the gelatin and glycerin in the ratio, heat and stir to completely dissolve the gelatin, add the ratio of ethyl paraben, and mix at 85 °. Incubate for 30 minutes at C, remove some water by vacuuming, so that the moisture content is 33%. After passing through 80 mesh sieve, transfer it to a stable plastic barrel. Incubate at 55-60 ° C for more than 12 hours. Obtain a glue solution; then use this glue solution to make a soft film with a uniform thickness and a certain elasticity according to conventional processes;
( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0. I 粒的软胶嚢, 即可。  (4) Making soft gelatin capsules: press the soft gelatin capsules into the contents of the soft gelatin capsules and press the soft gelatin capsules into 0.1 soft gelatin capsules.
实施例十八 本实施例为软胶嚢剂, 其中: Embodiment 18 This embodiment is a soft gel tincture, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 180份赤芍、 2份大豆植 物油。  The drug substance components of the contents of soft capsules are: 1 part of peppermint oil, 180 parts of red peony, and 2 parts of soybean vegetable oil.
软胶片由以下重量配比的组分组成: 3份明胶、 1.2份甘油、 0.5份水、 0.02份山梨酸。  The soft film is composed of the following weight ratio components: 3 parts gelatin, 1.2 parts glycerin, 0.5 parts water, 0.02 parts sorbic acid.
制备方法:  Preparation:
(1)、 按照实施例八步骤(1) 中提取方法提取赤芍, 得赤芍浸膏粉; (1) Extracting red peony according to the extraction method in step (1) of Example 8 to obtain red peony extract powder;
(2)、 取所述配比的大豆植物油, 加热至 55°C左右, 加入所述配比的薄 荷素油, 混匀, 再边搅拌边加入( 1 )步制得的赤芍浸膏粉, 直至加完后继续 搅拌 30分钟左右, 使混合均匀, 静置 12小时以上备用; (2) taking the proportion of soybean vegetable oil, heating it to about 55 ° C, adding the proportion of menthol oil, mixing well, and then adding the red chrysanthemum extract powder obtained in step (1) while stirring, Continue to stir for about 30 minutes after the addition is complete, make the mixture uniform, and let it stand for more than 12 hours;
(3)、 制备软胶片: 取适量纯化水, 加入所述配比的明胶和甘油, 加热 并搅拌使明胶完全溶化, 再加入所述配比的山梨酸, 混匀后在 85°C条件下保 温 30分钟, 抽真空除去部分水, 使其中的水分含量适宜, 再过 80目筛后转 入稳胶桶中, 在 55- 60°C条件下保温 12小时以上, 即制得胶液; 然后将此胶 液按常规工艺制成厚薄均匀且具有一定弹性的软胶片备用;  (3) Preparation of soft film: Take an appropriate amount of purified water, add the gelatin and glycerin in the ratio, heat and stir to completely dissolve the gelatin, add the sorbic acid in the ratio, and mix at 85 ° C. After holding for 30 minutes, vacuum remove part of the water to make the moisture content suitable. After passing through a 80 mesh sieve, transfer it to a stable plastic bucket and keep it at 55-60 ° C for more than 12 hours to obtain a glue solution. This glue solution is made into a soft film with uniform thickness and elasticity according to the conventional process for future use;
( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0. I 粒的软胶嚢, 即可。  (4) Making soft gelatin capsules: press the soft gelatin capsules into the contents of the soft gelatin capsules and press the soft gelatin capsules into 0.1 soft gelatin capsules.
实施例十九  Example 19
本实施例为软胶嚢剂, 其中:  This embodiment is a soft gel tincture, where:
软胶嚢内容物的原料药组分为: 1份薄荷素油、 100份白芍、 80份赤芍、 The drug substance components of the contents of soft capsules are: 1 part mint oil, 100 parts white peony, 80 parts red peony,
2份大豆植物油。 2 servings of soybean vegetable oil.
软胶片由以下重量配比的组分组成: 3份明胶、 1.2份甘油、 0.4份水、 0.01份尼泊金丙酯。  The soft film is composed of the following weight ratio components: 3 parts of gelatin, 1.2 parts of glycerin, 0.4 parts of water, 0.01 parts of paraben.
以上各实施例的制备方法:  Preparation method of the above embodiments:
(1)、 按照实施例八步骤(1) 中提取方法提取赤芍, 得赤芍浸膏粉; (1) Extracting red peony according to the extraction method in step (1) of Example 8 to obtain red peony extract powder;
(2)、 取所述配比的大豆植物油, 加热至 55°C左右, 加入所述配比的薄 荷素油, 混匀, 再边搅拌边加入(1)步制得的赤芍浸膏粉, 直至加完后继续 搅拌 30分钟左右, 使混合均匀, 静置 12小时以上备用; (2) Take the proportion of soybean vegetable oil, heat it to about 55 ° C, add the proportion of menthol oil, mix well, and then add the chitin extract powder obtained in step (1) while stirring, Continue to stir for about 30 minutes after the addition is complete, make the mixture uniform, and let it stand for more than 12 hours;
(3)、 制备软胶片: 取适量纯化水, 加入所述配比的明胶和甘油, 加热 并搅拌使明胶完全溶化, 再加入所述配比的尼泊金丙酯, 混勾后在 85°C条件 下保温 30分钟, 抽真空除去部分水, 使其中的水分含量为 28°/。, 再过 80目筛 后转入稳胶桶中, 在 55- 60°C条件下保温 12小时以上, 即制得胶液; 然后将 此胶液按常规工艺制成厚薄均匀且具有一定弹性的软胶片备用; ( 4 )制成软胶嚢:将软胶嚢内容物和软胶片上软胶嚢压制机压制成 0. 5g/ 粒的软胶嚢, 即可。 (3) Preparation of soft film: Take an appropriate amount of purified water, add the proportion of gelatin and glycerin, heat and stir to completely dissolve the gelatin, and then add the proportion of propyl paraben to the mixture. C was held for 30 minutes under the condition of C, and a portion of water was removed by vacuuming, so that the moisture content therein was 28 ° /. After passing through an 80-mesh sieve, it is transferred to a stable plastic barrel, and it is kept at 55-60 ° C for more than 12 hours to obtain a glue solution. Then, the glue solution is made into a uniform thickness with a certain elasticity according to conventional processes. Spare film (4) Making a soft gelatin capsule: the contents of the soft gelatin capsule and the soft gelatin tablet press on the soft gelatin capsule are pressed into a soft gelatin capsule of 0.5 g / granule.
上述各实施例中用到的药用辅料均购自合法的辅料生产厂家, 其中: 硬 脂酸镁为上海元吉化工有限公司产品; 玉米淀粉为江苏镇江市环宇药用辅料 厂产品; 明胶为青海明胶股份有限公司产品; 甘油为杭州亚太化工装备有限 公司产品; 尼泊金曱酯、 尼泊金乙酯和尼泊金丙酯均为安徽郎溪县新科化工 有限公司产品; 大豆油和花生油为深圳南海油脂工业有限公司产品; 茶油为 防城港新海油脂工业有限公司产品; 蜂蜡为大连桑地天然品有限公司产品; 大豆磷脂为北京美亚斯磷脂技术有限公司产品; 氢氧化钠为兰溪市广陇化工 原料有限公司产品; 丙烯酸树脂 II和丙烯酸树脂 III为湖州展望天明药业有限 公司产品。 上述各实施例中用到的肠溶型薄膜包衣为购自成都泰山薄膜包衣 厂生产的肠溶型薄膜包衣预混剂。  The pharmaceutical excipients used in the above examples were purchased from legal excipient manufacturers, among which: magnesium stearate is a product of Shanghai Yuanji Chemical Co., Ltd .; corn starch is a product of Zhenyu Huanyu Pharmaceutical Excipients Factory in Jiangsu; gelatin is Qinghai Products of Gelatin Co., Ltd .; glycerin is a product of Hangzhou Asia-Pacific Chemical Equipment Co., Ltd .; paraben, ethyl paraben and ethyl paraben are products of Xinke Chemical Co., Ltd. of Langxi County, Anhui; soybean oil and peanut oil are Products of Shenzhen Nanhai Oil Industry Co., Ltd .; tea oil is the product of Fangchenggang Xinhai Oil Industry Co., Ltd .; beeswax is the product of Dalian Sangdi Natural Products Co., Ltd .; soybean phospholipid is the product of Beijing Meiyas Phospholipid Technology Co., Ltd .; sodium hydroxide is the product of Lanxi Guanglong. Products of Chemical Materials Co., Ltd .; Acrylic Resin II and Acrylic Resin III are products of Huzhou Jiantianming Pharmaceutical Co., Ltd. The enteric film coating used in each of the above examples was an enteric film coating premix obtained from Chengdu Taishan Film Coating Factory.

Claims

权 利 要 求 Rights request
1、 一种治疗肠易激综合征的中药, 它含有以下重量配比的原料药: 1份 薄荷素油和 80-180份白芍 /赤芍。 1. A traditional Chinese medicine for treating irritable bowel syndrome, which contains the following weight ratio of raw materials: 1 part of peppermint oil and 80-180 parts of white peony / red peony.
2、 根据权利要求 1所述的治疗肠易激综合征的中药, 其特征在于: 它含 有以下重量配比的原料药: 1份薄荷素油和 100- 160份白芍 /赤芍。  2. The traditional Chinese medicine for treating irritable bowel syndrome according to claim 1, characterized in that it contains the following raw materials in weight ratio: 1 part of peppermint oil and 100-160 parts of white peony / red peony.
3、 根据权利要求 2所述的治疗肠易激综合征的中药, 其特征在于: 它含 有以下重量配比的原料药: 1份薄荷素油和 130份白芍 /赤芍。  3. The traditional Chinese medicine for treating irritable bowel syndrome according to claim 2, characterized in that: it contains the following raw materials in weight ratio: 1 part of peppermint oil and 130 parts of white peony / red peony.
4、 才艮据权利要求 1所述的中药, 其特征在于: 用常规提取方法处理白芍 /赤芍, 得到的提取物与 1份薄荷素油混合而成。  4. The traditional Chinese medicine according to claim 1, characterized in that the white peony / red peony is treated by a conventional extraction method, and the obtained extract is mixed with 1 part of peppermint oil.
5、 根据权利要求 4所述的中药, 其特征在于: 所述的用常规方法处理白 芍 /赤芍得到的提取物为用水提取、 纯化得到的浸膏粉。  5. The traditional Chinese medicine according to claim 4, characterized in that: the extract obtained by treating white peony / red peony with a conventional method is an extract powder obtained by water extraction and purification.
6、 根据权利要求 5所述的中药, 其特征在于: 该中药的剂型为片剂、 硬 胶嚢剂或软胶嚢剂。  6. The traditional Chinese medicine according to claim 5, wherein the dosage form of the traditional Chinese medicine is a tablet, a hard gel liniment or a soft gel liniment.
7、根据权利要求 6所述的中药,其特征在于: 该中药的剂型为软胶囊剂, 它由包含上述药物成份的软胶嚢内容物和覆在其表面的软胶嚢壳构成; 且软 胶嚢内容物中还含有选自植物油、 大豆磷脂、 蜂蜡、 甘油、 聚乙二醇、 丙二 醇和异丙醇中的任意一种或几种药用辅料; 软胶嚢壳中含有明胶、 甘油和水。  7. The traditional Chinese medicine according to claim 6, characterized in that: the dosage form of the traditional Chinese medicine is a soft capsule, which is composed of the contents of a soft capsule containing the above-mentioned pharmaceutical ingredients and a soft capsule shell covering the surface; and The capsule contents also contain any one or more medicinal excipients selected from vegetable oil, soybean phospholipids, beeswax, glycerin, polyethylene glycol, propylene glycol, and isopropanol; soft capsule shells contain gelatin, glycerin and water.
8、 根据权利要求 7所述的中药, 其特征在于: 所述的软胶嚢壳中还含有 山梨酸、 丙烯酸树脂 Π、 丙烯酸树脂 III、 水、 二氧化钛、 氢氧化钠、 蔗糖、 尼泊金乙酯、 尼泊金曱酯和尼泊金丙酯中的任意一种或几种。  8. The traditional Chinese medicine according to claim 7, characterized in that: the soft gum shell further contains sorbic acid, acrylic resin II, acrylic resin III, water, titanium dioxide, sodium hydroxide, sucrose, nipagin B Any one or more of esters, parabens and propyl parabens.
9、 根据权利要求 8所述的中药, 其特征在于: 所述的软胶嚢内容物中还 含有如下重量比的组分: 1. 5-3份大豆油、 0. 02- 0. 08份大豆磷脂和 0. 02- 0. 08 份蜂蜡; 软胶嚢壳的组分为: 3份明胶、 1. 2- 1. 8份甘油、 0. 6-1. 0份丙烯酸 树脂 II、 0. 2-0. 6份丙烯酸树脂 III、 0. 008-0. 012份尼泊金乙酯、 0. 18-0. 24 份氢氧化钠、 2-3份水。  9. The traditional Chinese medicine according to claim 8, characterized in that: the contents of the soft gum tincture further contain the following components by weight ratio: 1. 5-3 parts of soybean oil, 0.02-0.08 parts Soy phospholipids and 0.02 to 0. 08 parts of beeswax; the components of the soft gum shell are: 3 parts of gelatin, 1. 2-1. 8 parts of glycerin, 0.6-1.0 parts of acrylic resin II, 0. 2-0. 6 parts of acrylic resin III, 0. 008-0. 012 parts of paraben ethyl ester, 0. 18-0. 24 parts of sodium hydroxide, 2-3 parts of water.
10、 根据权利要求 9所述的中药, 其特征在于: 所述的软胶嚢内容物中 含有如下重量比的组分为: 1份薄荷素油、 由 130份白芍 /赤芍得到的浸膏粉、 2. 2份大豆油、 0. 05份大豆磷脂和 0. 05份蜂蜡; 软胶嚢壳的组分为: 3份明 胶、 1. 5份甘油、 0. 8份丙烯酸树脂 II、 0. 4份丙烯酸树脂 III、 0. 01份尼泊金 乙酯、 0. 21份氢氧化钠、 2. 5份水。  10. The traditional Chinese medicine according to claim 9, characterized in that: the content of the soft gum tincture contains the following components in a weight ratio of: 1 part of peppermint oil, 130 parts of extract of white tincture / red tincture Powder, 2.2 parts of soybean oil, 0.05 parts of soybean phospholipids, and 0.05 parts of beeswax; the components of the soft gelatin shell are: 3 parts of gelatin, 1.5 parts of glycerin, 0.8 parts of acrylic resin II, 0 4 parts of acrylic resin III, 0.01 part of paraben ethyl ester, 0.21 part of sodium hydroxide, 2.5 parts of water.
11、根据权利要求 6-10中任一项所述的中药, 其特征在于: 所述的片剂、 硬胶嚢剂或软胶嚢剂表面还包有一层肠溶型薄膜包衣。 11. The traditional Chinese medicine according to any one of claims 6 to 10, wherein the surface of the tablet, hard gel tincture or soft gel tincture is further coated with an enteric film coating.
12、 一种制备按照权利要求 5所述的中药的方法, 包括如下步驟:12. A method for preparing a traditional Chinese medicine according to claim 5, comprising the following steps:
( 1 )提取白芍 /赤芍: 取所述配比的白芍或赤芍药材, 加入 6-10倍量水 煎煮提取 2- 4次, 每次 1-3小时, 过滤, 并将合并的滤液浓缩至相对密度为 1. 10-1. 20, 加入 2-4倍量 80- 95%的乙醇溶液, 静置沉淀 12-48小时, 过滤, 将滤液回收乙醇并浓缩至相对密度为 1. 10-1. 20 , 加入等量的 0. 1-0. 3mol /L 的 NaHC03溶液, 搅拌使溶解, 加入 3- 5倍量乙酸乙酯萃取 2- 4次, 合并乙酸 乙酯萃取液, 回收乙酸乙酯至近干, 再加入 2-5倍量 75- 85%的乙醇溶液使溶 解, 过滤, 然后将滤液回收乙醇并浓缩至相对密度为 1. 10- 1. 20 , 喷雾干燥, 得白芍 /赤芍浸膏粉; (1) Extracting white scallion / red scallion: take the ratio of the white scallion or scallion medicinal materials, add 6-10 times the amount of water to cook and extract 2-4 times, each time 1-3 hours, filter, and combine The filtrate was concentrated to a relative density of 1.10-1.20, 2-4 times the amount of an 80-95% ethanol solution was added, and the precipitate was allowed to stand for 12-48 hours, filtered, and the filtrate was recovered to ethanol and concentrated to a relative density of 1. 10-1. 20, add equal amount of 0.1-0.3mol / L NaHC0 3 solution, stir to dissolve, add 3-5 times the amount of ethyl acetate to extract 2-4 times, and combine the ethyl acetate extracts Recover ethyl acetate to near dry, then add 2-5 times the amount of 75-85% ethanol solution to dissolve, filter, and then recover the filtrate to ethanol and concentrate to a relative density of 1. 10- 1. 20, spray-dried to obtain Paeonia lactiflora / red paeonia extract powder;
( 2 )制成制剂: 取所述配比的薄荷素油, 与 (1 )步制得的白芍 /赤芍浸 膏粉混匀后按常规技术制成各种制剂。  (2) Preparation of preparations: Take the mentioned ratio of menthol oil and mix it with the white scallion / red scallion extract powder prepared in step (1) to prepare various preparations according to conventional techniques.
13、 一种按照权利要求 12所述的方法, 其中步骤(2)所述的剂型为软胶 嚢剂;且其中软胶嚢内容物按如下程序制备:取 1. 5- 3份大豆油,加热至 55-60 °C , 加入 0. 02-0. 08份的大豆磷脂和 0. 02-0. 08份蜂蜡, 使溶解并混匀后, 加入所述配比的薄荷素油, 混匀, 再边搅拌边加入(1 ) 步制得的白芍 /赤芍 浸膏粉, 继续搅拌 20- 60分钟, 使之充分混匀, 静置 8小时以上备用;  13. A method according to claim 12, wherein the dosage form of step (2) is a soft gum tincture; and wherein the contents of the soft gum tincture are prepared according to the following procedure: take 1.5 to 3 parts soybean oil, After heating to 55-60 ° C, 0.02-0. 08 parts of soybean phospholipid and 0.02-0. 08 parts of beeswax are added, and after dissolving and mixing, add the proportion of peppermint oil and mix, Add the white scallion / red scallion extract powder prepared in step (1) while stirring, continue to stir for 20-60 minutes, make it fully mixed, and let it stand for more than 8 hours for use;
且按如下程序制备软胶片:先用 0. 18-0. 24份氢氧化钠配制成 3- 10%的氢 氧化钠溶液备用; 另取适量纯化水,加入 0. 6-1. 0份丙烯酸树脂 II和 0. 2-0. 6 份丙烯酸树脂 III, 搅拌 20-60分钟, 静置 40-120分钟, 再边搅拌边加入预先 配制好的氢氧化钠溶液, 碱化 40-100分钟后, 在搅拌条件下加热至 80- 85 °C 并保温 30-60分钟,再加入 3份明胶、 1. 2-1. 8份甘油和 0. 008-0. 012份尼泊 金乙酯,继续加热并搅拌使明胶完全溶化,在 80- 85 °C条件下保温 30-60分钟, 抽真空除去部分水, 使其中的水分控制在 18-35°/。, 再过 80目筛后在 55- 60°C 条件下保温 10小时以上以便稳胶, 即制得胶液; 然后将此胶液按常规工艺制 成软胶片备用;  0-1 acrylic acid, and the following steps were used to prepare a soft film: first use 0. 18-0. 24 parts of sodium hydroxide to prepare a 3- 10% sodium hydroxide solution for use; another appropriate amount of purified water was added, 0.6-1. 0 parts acrylic acid Resin II and 0.2-2. 6 parts of acrylic resin III, stirred for 20-60 minutes, left to stand for 40-120 minutes, and then added the pre-prepared sodium hydroxide solution while stirring. After alkalizing for 40-100 minutes, Under stirring conditions, heat to 80-85 ° C and keep for 30-60 minutes, then add 3 parts of gelatin, 1. 2-1. 8 parts of glycerin and 0.008-0. 012 parts of paraben ethyl ester, continue heating Stir the gelatin completely, keep it at 80-85 ° C for 30-60 minutes, and remove some of the water by vacuum to control the water content to 18-35 ° /. After passing through an 80-mesh sieve and holding at 55-60 ° C for more than 10 hours to stabilize the glue, the glue solution is prepared; then the glue solution is made into a soft film according to the conventional process for later use;
且将软胶嚢内容物和软胶片制成软胶嚢。  In addition, the contents of the soft capsule and the soft film are made into a soft capsule.
14、 一种按照权利要求 12或 13所述的方法, 其中还包括步驟:  14. A method according to claim 12 or 13, further comprising the steps:
. (3) 将步骤(2)制得的制剂外包有一层肠溶型薄膜包衣。  (3) The preparation prepared in step (2) is coated with an enteric film coating.
PCT/CN2005/000155 2004-02-05 2005-02-04 Chinese medicine for treatment of irritable bowel sysndrome and the preparation thereof WO2005074952A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN200410021765 2004-02-05
CN200410021765.X 2004-02-05
CN2004100796671A CN1660259A (en) 2004-02-05 2004-12-22 Chinese traditional medicine for treating imitable bowel syndrome and preparation method
CN200410079667.1 2004-12-22

Publications (1)

Publication Number Publication Date
WO2005074952A1 true WO2005074952A1 (en) 2005-08-18

Family

ID=34839277

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2005/000155 WO2005074952A1 (en) 2004-02-05 2005-02-04 Chinese medicine for treatment of irritable bowel sysndrome and the preparation thereof

Country Status (2)

Country Link
CN (1) CN1660259A (en)
WO (1) WO2005074952A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3263114A4 (en) * 2015-02-26 2018-09-05 Zuoguang Zhang Use of albiflorin or pharmaceutically acceptable salt for prevention and/or treatment of irritable bowel syndrome

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103585289B (en) * 2012-08-15 2016-09-28 四川济生堂药业有限公司 A kind of prevention or the pharmaceutical composition for the treatment of irritable bowel syndrome
CN107510716B (en) * 2016-06-17 2020-06-30 上海凯宝药业股份有限公司 Pharmaceutical composition for treating irritable bowel syndrome and preparation method and application thereof
CN106177062A (en) * 2016-08-30 2016-12-07 山西亿科宏泰生物科技有限公司 A kind of pharmaceutical composition treating irritable bowel syndrome and preparation method thereof
IT201700082310A1 (en) * 2017-07-20 2017-10-20 Gianfranco Caramelli "Treatment of complex gastrointestinal symptoms associated with IBS (Irritable bowel syndrome) with microencapsulated Peppermint essential oil associated with natural principles"
CN109260309A (en) * 2018-11-20 2019-01-25 山东罗欣乐康制药有限公司 A kind of preparation method of the Chinese medicinal composition granules of warm in pain

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1040030A (en) * 1988-07-29 1990-02-28 安徽医科大学临床药理研究所 The extraction process of effective component of paeonia lactiflora

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1040030A (en) * 1988-07-29 1990-02-28 安徽医科大学临床药理研究所 The extraction process of effective component of paeonia lactiflora

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
WU Y. ET AL: "Effect Observation of one Chinese Medicine Enema for the treatment of irritable colon syndrome with the characteristic of diarrhoea.", INFORMATION ON TRADITIONAL CHINESE MEDICINE., vol. 4, 1995, pages 41 *
ZHANG Z. ET AL: "Traditional Chinese Pharmaceutics.", CHINA PRESS FOR TRADITIONAL CHINESE MEDICINE AND PHARMACY., 2003, pages 356 - 357 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3263114A4 (en) * 2015-02-26 2018-09-05 Zuoguang Zhang Use of albiflorin or pharmaceutically acceptable salt for prevention and/or treatment of irritable bowel syndrome
US10350230B2 (en) 2015-02-26 2019-07-16 Zuoguang Zhang Use of albiflorin or pharmaceutically acceptable salt for prevention and/or treatment of irritable bowel syndrome
AU2015384083B2 (en) * 2015-02-26 2021-02-18 Zuoguang Zhang Use of albiflorin or pharmaceutically acceptable salt for prevention and/or treatment of irritable bowel syndrome

Also Published As

Publication number Publication date
CN1660259A (en) 2005-08-31

Similar Documents

Publication Publication Date Title
CN109674958B (en) Traditional Chinese medicine composition with effect of reducing uric acid and preparation method and application thereof
CN108853217A (en) A kind of pharmaceutical composition and its application for treating chicken Mycoplasma synoviae
CN1201786C (en) Traditional Chinese medicine composition for curing child&#39;s dyspepsia and cough and its preparing method
CN101703684B (en) Medicament for treating allergic purpura and preparation method thereof
WO2005074952A1 (en) Chinese medicine for treatment of irritable bowel sysndrome and the preparation thereof
CN109999117A (en) Prevent and treat enteritis, bacillary dysentery, dysentery, intractable diarrhea Chinese medicine composition
CN105434915A (en) Pharmaceutical composition for treating urolithiasis for dogs and cats and preparation method of pharmaceutical composition
CN101693084B (en) Medical composition for treating epigastric pain yin deficiency syndrome and preparation method thereof
CN114712478B (en) Traditional Chinese medicine composition for treating intestinal diseases, preparation and preparation method thereof
CN115054664A (en) A pharmaceutical composition for treating cancer pain, and its preparation method
CN110327435B (en) Traditional Chinese medicine composition for treating ulcerative colitis and chronic proctitis and application thereof
CN102824414A (en) Medicinal tea used for treating constipation
CN108815448B (en) Traditional Chinese medicine granules for treating chronic colitis
CN101618204A (en) Medicine composition for treating cold of insufficiency type and stomachache and preparation method thereof
CN1261156C (en) Medicine for treating chronic gastroenteritis and colitis
CN115671219B (en) Traditional Chinese medicine composition for treating gout and preparation method and application thereof
CN103893512B (en) A kind of Chinese medicine composition for treating urarthritis
CN115779046B (en) Traditional Chinese medicine composition, traditional Chinese medicine preparation and application for preventing and treating diabetes
CN108704036A (en) A kind of Chinese traditional compound medicine and preparation method thereof for treating gout
CN116808110B (en) Intestine-moistening and bowel-relaxing formula and preparation method thereof
CN102727624B (en) New application of enteritis peaching composition on treatment of chronic prostatitis
CN101926955B (en) Medicament for treating stomach illness
CN1088378C (en) Oral Chinese medicine liquid for treating chronic superficial gastritis and its preparation
CN106727958A (en) It is a kind of to treat pharmaceutical composition of alcoholic hepatitis and preparation method thereof
CN111759872A (en) Medicine for treating hypertension and preparation method thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase